The Gonadotropin Hormones and Their Receptors

Yen & Jaffe's Reproductive Endocrinology

Volumn , Issue , 2009, Pages 35-55

  Ascoli, Mario ^a   Puett, David ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884013649     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4907-4.00002-4     Document Type: Chapter

References (493)

1. Hearn M.T.W., Gomme P.T. Molecular architecture and biorecognition processes of the cystine knot protein superfamily: Part I. The glycoprotein hormones. J Mol Recognit 2000, 13:223-278.
2. Fiddes J.C., Goodman H.M. The cDNA for the beta-subunit of human chorionic-gonadotropin suggests evolution of a gene by readthrough into the 3'-untranslated region. Nature 1980, 286:684-687.
3. Talmadge K., Vamvakopoulos N.C., Fiddes J.C. Evolution of the genes for the beta-subunits of human chorionic-gonadotropin and luteinizing-hormone. Nature 1984, 307:37-40.
4. Nakav S., Jablonka-Shariff A., Kaner S., et al. The LH beta gene of several mammals embeds a carboxyl-terminal peptide-like sequence revealing a critical role for mucin oligosaccharides in the evolution of lutropin to chorionic gonadotropin in the animal phyla. J Biol Chem 2005, 280:16676-16684.
5. Lapthorn A.J., Harris D.C., Littlejohn A., et al. Crystal-structure of human chorionic-gonadotropin. Nature 1994, 369:455-461.
6. Wu H., Lustbader J.W., Liu Y., et al. Structure of human chorionic-gonadotropin at 2.6-angstrom resolution from MAD analysis of the selenomethionyl protein. Structure 1994, 2:545-558.
7. Tegoni M., Spinelli S., Verhoeyen M., et al. Crystal structure of a ternary complex between human chorionic gonadotropin (hCG) and two FV fragments specific for the alpha and beta-subunits. J Mol Biol 1999, 289:1375-1385.
8. Fox K.M., Dias J.A., Van Roey P. Three-dimensional structure of human follicle-stimulating hormone. Mol Endocrinol 2001, 15:378-389.
9. Fan Q.R., Hendrickson W.A. Structural biology of glycoprotein hormones and their receptors. Endocrine 2005, 26:179-188.
10. Fan Q.R., Hendrickson W.A. Structure of human follicle-stimulating hormone in complex with its receptor. Nature 2005, 433:269-277.
11. Fan Q.R., Hendrickson W.A. Assembly and structural characterization of an authentic complex between human follicle stimulating hormone and a hormone-binding ectodomain of its receptor. Mol Cell Endocrinol 2007, 260:73-82.
12. Moore W.T., Burleigh B.D., Ward D.N. Chorionic gonadotropin: comparative studies and comments on relationships to other glycoprotein hormones. Chorionic Gonadotropin 1980, 89-126. Plenum Press, New York. S.J. Segal (Ed.).
13. DeBeer T., VanZuylen C., Leeflang B.R., et al. NMR studies of the free alpha subunit of human chorionic gonadotropin: structural influences of N-glycosylation and the beta subunit on the conformation of the alpha subunit. Eur J Biochem 1996, 241:229-242.
14. Erbel P.J.A., Karimi-Nejad Y., De Beer T., et al. Solution structure of the alpha-subunit of human chorionic gonadotropin. Eur J Biochem 1999, 260:490-498.
15. Puett D., Ryan R.J., Stevens V.C. Circular dichroic and immunological properties of human chorio-gonadotropin beta carboxyl terminal peptides. Int J Peptide Protein Res 1982, 19:506-513.
16. Rock E.P., Czaplicki J., Milon A. Structural analysis of the carboxyl terminal peptide from human chorionic gonadotropin beta-subunit by two-dimensional nuclear magnetic resonance spectroscopy. Am J Reprod Immunol 1996, 35:156-162.
17. Heikoop J.C., Grootenhuis P.D.J., Blaauw M., et al. Expression of a bioactive, single-chain choriogonadotropin in dictyostelium discoideum. Eur J Biochem 1998, 256:359-363.
18. Erbel P.J.A., Haseley S.R., Kamerling J.P., et al. Studies on the relevance of the glycan at Asn-52 of the alpha-subunit of human chorionic gonadotropin in the alpha-beta dimer. Biochem J 2002, 364:485-495.
19. Erbel P.J.A., Karimi-Nejad Y., van Kuik J.A., et al. Effects of the N-linked glycans on the 3D structure of the free alpha-subunit of human chorionic gonadotropin. Biochemistry 2000, 39:6012-6021.
20. Ulloa-Aguirre A. (ed). Isoforms of Circulating FSH 1996, Parthenon, New York.
21. Ulloa-Aguirre A., Maldonado A., Damian-Matsumura P., et al. Endocrine regulation of gonadotropin glycosylation. Arch Med Res 2001, 32:520-532.
22. Dias J.A. Is there any physiological role for gonadotrophin oligosaccharide heterogeneity in humans? II. A biochemical point of view. Hum Reprod 2001, 16:825-830.
23. Fares F. The role of o-linked and N-linked oligosaccharides on the structure-function of glycoprotein hormones: development of agonists and antagonists. Biochim Biophys Acta 2006, 1760:560-567.
24. Campo S., Ambao V., Creus S., et al. Carbohydrate complexity and proportions of serum FSH isoforms in the male: lectin-based studies. Mol Cell Endocrinol 2007, 260:197-204.
25. Cole L.A., Khanlian S.A. Hyperglycosylated hCG: a variant with separate biological functions to regular hCG. Mol Cell Endocrinol 2007, 260:228-236.
26. Handschuh K., Guibourdenche J., Tsatsaris V., et al. Human chorionic gonadotropin produced by the invasive trophoblast but not the villous trophoblast promotes cell invasion and is down-regulated by peroxisome proliferator-activated receptor-gamma. Endocrinology 2007, 148:5011-5019.
27. Green E.D., Boime I., Baenziger J.U. Differential processing of asn-linked oligosaccharides on pituitary glycoprotein hormones: implications for biologic function. Mol Cell Biochem 1986, 72:81-100.
28. Bousfield G.R., Butnev V.Y., Walton W.J., et al. All-or-none N-glycosylationin primate follicle-stimulating hormone beta-subunits. Mol Cell Endocrinol 2007, 260:40-48.
29. Gervais A., Hammel Y.A., Pelloux S., et al. Glycosylation of human recombinant gonadotrophins: characterization and batch-to-batch consistency. Glycobiology 2003, 13:179-189.
30. Bousfield G.R., Butnev V.Y., Dalpathado D.S., et al. Site-specific glycosylation analysis of hFSH isoforms. Glycobiology 2006, 16. 1120-1120.
31. Toll H., Berger P., Hofmann A., et al. Glycosylation patterns of human chorionic gonadotropin revealed by liquid chromatography-mass spectrometry and bioinformatics. Electrophoresis 2006, 27:2734-2746.
32. Dalpathado D.S., Irungu J., Go E.P., et al. Comparative glycomics of the glycoprotein follicle stimulating hormone: glycopeptide analysis of isolates from two mammalian species. Biochemistry 2006, 45:8665-8673.
33. Valmu L., Alfthan H., Hotakainen K., et al. Site-specific glycan analysis of human chorionic gonadotropin beta-subunit from malignancies and pregnancy by liquid chromatography-electrospray mass spectrometry. Glycobiology 2006, 16:1207-1218.
34. Kicman A.T., Parkin M.C., Iles R.K. An introduction to mass spectrometry based proteomics: detection and characterization of gonadotropins and related molecules. Mol Cell Endocrinol 2007, 260:212-227.
35. Liu C.L., Bowers L.D. Mass spectrometric characterization of the beta-subunit of human chorionic gonadotropin. J Mass Spectrom 1997, 32:33-42.
36. Kessler M.J., Mise T., Ghai R.D., et al. Structure and location of the o-glycosidic carbohydrate units of human chorionic-gonadotropin. J Biol Chem 1979, 254:7909-7914.
37. Huth J.R., Perini F., Lockridge O., et al. Protein-folding and assembly in-vitro parallel intracellular folding and assembly: catalysis of folding and assembly of the human chorionic-gonadotropin alpha-beta dimer by protein disulfide-isomerase. J Biol Chem 1993, 268:16472-16482.
38. Ruddon R.W., Bedows E. Assisted protein folding. J Biol Chem 1997, 272:3125-3128.
39. Ruddon R.W., Sherman S.A., Bedows E. Protein folding in the endoplasmic reticulum: lessons from the human chorionic gonadotropin beta subunit. Protein Sci 1996, 5:1443-1452.
40. Darling R.J., Ruddon R.W., Perini F., et al. Cystine knot mutations affect the folding of the glycoprotein hormone alpha-subunit: differential secretion and assembly of partially folded intermediates. J Biol Chem 2000, 275:15413-15421.
41. Darling R.J., Wilken J.A., Miller-Lindbolm A.K., et al. Functional contributions of noncysteine residues within the cystine knots of human chorionic gonadotropin subunits. J Biol Chem 2001, 276:10692-10699.
42. Darling R.J., Wilken J.A., Ruddon R.W., et al. Intracellular folding pathway of the cystine knot-containing glycoprotein hormone alpha-subunit. Biochemistry 2001, 40:577-585.
43. Wilken J.A., Bedows E. Disulfide bond rearrangement during formation of the chorionic gonadotropin beta-subunit cystine knot in vivo. Biochemistry 2004, 43:5109-5118.
44. Wilken J.A., Bedows E. A novel four-amino acid determinant defines conformational freedom within chorionic gonadotropin beta-subunits. Biochemistry 2007, 46:4417-4424.
45. Xing Y.N., Williams C., Campbell R.K., et al. Threading of a glycosylated protein loop through a protein hole: implications for combination of human chorionic gonadotropin subunits. Protein Sci 2001, 10:226-235.
46. Xing Y.N., Myers R.V., Cao D.H., et al. Glycoprotein hormone assembly in the endoplasmic reticulum: I. The glycosylated end of human alpha-subunit loop 2 is threaded through a beta-subunit hole. J Biol Chem 2004, 279:35426-35436.
47. Xing Y.N., Myers R.V., Cao D.H., et al. Glycoprotein hormone assembly in the endoplasmic reticulum: II. Multiple roles of a redox sensitive beta-subunit disulfide switch. J Biol Chem 2004, 279:35437-35448.
48. Xing Y.N., Myers R.V., Cao D.H., et al. Glycoprotein hormone assembly in the endoplasmic reticulum: III. The seatbelt and its latch site determine the assembly pathway. J Biol Chem 2004, 279:35449-35457.
49. Xing Y.N., Myers R.V., Cao D.H., et al. Glycoprotein hormone assembly in the endoplasmic reticulum: IV. Probable mechanism of subunit docking and completion of assembly. J Biol Chem 2004, 279:35458-35468.
50. Singh V., Merz W.E. Disulfide bond formation is not required for human chorionic gonadotropin subunit association: studies with dithiothreitol in JEG-3 cells. J Biol Chem 2000, 275:11765-11770.
51. Roig J., Krause J.M., Berger P., et al. Time-dependent folding of immunological epitopes of the human chorionic gonadotropin beta-subunit. Mol Cell Endocrinol 2007, 260:12-22.
52. Merz W.E., Krause J.M., Roig J., et al. Non-assembled human chorionic gonadotropin subunits and αα-homodimers use fast-track processing in the secretory pathway in contrast to {αβ}-heterodimers. Endocrinology 2007, 148:5831-5841.
53. Krause J.M., Berger P., Roig J., et al. Rapid maturation of glycoprotein hormone free alpha-subunit (gphalpha) and gphalpha alpha homodimers. Mol Endocrinol 2007, 21:2551-2564.
54. Peng K.C., Puett D., Brewer J.M. Homodimer formation by the individual subunits of bovine lutropin as determined by sedimentation equilibrium. J Mol Endocrinol 1997, 18:259-265.
55. Butler S.A., Laidler P., Porter J.R., et al. The beta-subunit of human chorionic gonadotrophin exists as a homodimer. J Mol Endocrinol 1999, 22:185-192.
56. Lobel L., Pollak S., Wang S.J., et al. Expression and characterization of recombinant beta-subunit hCG homodimer. Endocrine 1999, 10:261-270.
57. Berger P., Gruschwitz M., Spoettl G., et al. Human chorionic gonadotropin (hCG) in the male reproductive tract. Mol Cell Endocrinol 2007, 260:190-196.
58. Nemansky M., Moy E., Lyons C.D., et al. Human endometrial stromal cells generate uncombined alpha-subunit from human chorionic gonadotropin, which can synergize with progesterone to induce decidualization. J Clin Endocrinol Metab 1998, 83:575-581.
59. Hsu S.Y., Nakabayashi K., Nishi S., et al. Activation of orphan receptors by the hormone relaxin. Science 2002, 295:671-674.
60. Nakabayashi K., Matsumi H., Bhalla A., et al. Thyrostimulin, a heterodimer of two new human glycoprotein hormone subunits, activates the thyroid-stimulating hormone receptor. J Clin Invest 2002, 109:1445-1452.
61. Szkudlinski M.W., Teh N.G., Grossmann M., et al. Engineering human glycoprotein hormone superactive analogues. Nat Biotechnol 1996, 14:1257-1263.
62. Shao K., Purohit S., Bahl O.P. Effect of modification of all loop regions in the alpha- and beta-subunits of human choriogonadotropin on its signal transduction activity. Mol Cell Endocrinol 1996, 122:173-182.
63. Sairam M.R. Role of carbohydrates in glycoprotein hormone signal transduction. FASEB J 1989, 3:1915-1926.
64. Matzuk M.M., Keene J.L., Boime I. Site specificity of the chorionic-gonadotropin N-linked oligosaccharides in signal transduction. J Biol Chem 1989, 264:2409-2414.
65. Thotakura N.R., Blithe D.L. Glycoprotein hormones: glycobiology of gonadotropins, thyrotropin and free alpha-subunit. Glycobiology 1995, 5:3-10.
66. Krystek S.R., Dias J.A., Andersen T.T. Identification of a subunit contact site of the alpha-subunit of follitropin. Pept Res 1992, 5:165-168.
67. Liu C., Roth K.E., Shepard B.A.L., et al. Site-directed alanine mutagenesis of Phe(33), Arg(35), and Arg(42)-Ser(43)-Lys(44) in the human gonadotropin alpha-subunit. J Biol Chem 1993, 268:21613-21617.
68. Xia H.Y., Chen F., Puett D. A region in the human glycoprotein hormone alpha-subunit important in holoprotein formation and receptor-binding. Endocrinology 1994, 134:1768-1770.
69. Chen F., Wang Y., Puett D. The carboxy-terminal region of the glycoprotein hormone alpha-subunit: contributions to receptor-binding and signaling in human chorionic-gonadotropin. Mol Endocrinol 1992, 6:914-919.
70. Yoo J.K., Zeng H.W., Ji I.H., et al. COOH-terminal amino-acids of the alpha-subunit play common and different roles in human choriogonadotropin and follitropin. J Biol Chem 1993, 268:13034-13042.
71. Matzuk M.M., Hsueh A.J.W., Lapolt P., et al. The biological role of the carboxyl-terminal extension of human chorionic-gonadotropin beta-subunit. Endocrinology 1990, 126:376-383.
72. Chen F., Wang Y., Puett D. Role of the invariant aspartic acid-99 of human choriogonadotropin-beta in receptor-binding and biological activity. J Biol Chem 1991, 266:19357-19361.
73. Morbeck D.E., Roche P.C., Keutmann H.T., et al. A receptor-binding site identified in the region 81-95 of the beta-subunit of human luteinizing-hormone (LH) and chorionic-gonadotropin (HCG). Mol Cell Endocrinol 1993, 97:173-181.
74. Roth K.E., Liu C., Shepard B.A., et al. The flanking amino-acids of the human follitropin beta-subunit 33-53 region are involved in assembly of the follitropin heterodimer. Endocrinology 1993, 132:2571-2577.
75. Huang J.N., Chen F., Puett D. Amino carboxyl-terminal deletion mutants of human choriogonadotropin-beta. J Biol Chem 1993, 268:9311-9315.
76. Huang J.N., Puett D. On the role of the invariant glutamine at position-54 in the human choriogonadotropin beta-subunit. Mol Cell Biochem 1994, 136:183-186.
77. Xia H.Y., Fernandez L.M., Puett D. Replacement of the invariant tyrosine in the cagy region of the human chorionic-gonadotropin beta subunit. Mol Cell Endocrinol 1993, 92:R1-R5.
78. Xia H.Y., Puett D. Identification of conserved amino-acid-residues in the beta-subunit of human choriogonadotropin important in holoprotein formation. J Biol Chem 1994, 269:17944-17953.
79. Hu S.B., Johnson L., Roche P.C., et al. A functional determinant in human luteinizing hormone and chorionic gonadotropin: differential effect of mutations about beta-gln-s4. Endocrinology 1997, 138:1627-1633.
80. Roy S., Setlur S., Gadkari R.A., et al. Translational fusion of two beta-subunits of human chorionic gonadotropin results in production of a novel antagonist of the hormone. Endocrinology 2007, 148:3977-3986.
81. Eldeiry S., Kaetzel D., Kennedy G., et al. Site-directed mutagenesis of the human chorionic-gonadotropin beta-subunit: bioactivity of a heterologous hormone, bovine alpha-human des-(122-145)-beta. Mol Endocrinol 1989, 3:1523-1528.
82. Moyle W.R., Matzuk M.M., Campbell R.K., et al. Localization of residues that confer antibody-binding specificity using human chorionic-gonadotropin luteinizing hormone-beta subunit chimeras and mutants. J Biol Chem 1990, 265:8511-8518.
83. Campbell R.K., Deanemig D.M., Moyle W.R. Conversion of human choriogonadotropin into a follitropin by protein engineering. Proc Natl Acad Sci U S A 1991, 88:760-764.
84. Campbell R.K., Bergert E.R., Wang Y.H., et al. Chimeric proteins can exceed the sum of their parts: implications for evolution and protein design. Nat Biotechnol 1997, 15:439-443.
85. Dias J.A., Zhang Y.Q., Liu X.X. Receptor-binding and functional-properties of chimeric human follitropin prepared by an exchange between a small hydrophilic intercysteine loop of human follitropin and human lutropin. J Biol Chem 1994, 269:25289-25294.
86. Slaughter S., Wang Y.H., Myers R.V., et al. The lutropin beta-subunit n-terminus facilitates subunit combination by offsetting the inhibitory effects of residues needed for LH activity. Mol Cell Endocrinol 1995, 112:21-25.
87. Han Y., Bernard M.P., Moyle W.R. hCG beta residues 94-96 alter LH activity without appearing to make key receptor contacts. Mol Cell Endocrinol 1996, 124:151-161.
88. Grossmann M., Szkudlinski M.W., Wong R., et al. Substitution of the seat-belt region of the thyroid-stimulating hormone (TSH) beta-subunit with the corresponding regions of choriogonadotropin or follitropin confers luteotropic but not follitropic activity to chimeric TSH. J Biol Chem 1997, 272:15532-15540.
89. Cosowsky L., Lin W., Han Y., et al. Influence of subunit interactions on lutropin specificity: implications for studies of glycoprotein hormone function. J Biol Chem 1997, 272:3309-3314.
90. Wang Y.H., Bernard M.P., Moyle W.R. Bifunctional hCG analogs adopt different conformations in LH and FSH receptor complexes. Mol Cell Endocrinol 2000, 170:67-77.
91. Narayan P., Wu C.B., Puett D. Functional expression of yoked human chorionic-gonadotropin in baculovirus-infected insect cells. Mol Endocrinol 1995, 9:1720-1726.
92. Sugahara T., Pixley M.R., Minami S., et al. Biosynthesis of a biologically-active single peptide-chain containing the human common alpha-subunits and chorionic-gonadotropin beta-subunits in tandem. Proc Natl Acad Sci U S A 1995, 92:2041-2045.
93. Sugahara T., Grootenhuis P.D.J., Sato A., et al. Expression of biologically active fusion genes encoding the common alpha subunit and either the CG beta or FSH beta subunits: role of a linker sequence. Mol Cell Endocrinol 1996, 125:71-77.
94. Garcia Campayo V., Sato A., Hirsch B., et al. Design of stable biologically active recombinant lutropin analogs. Nat Biotechnol 1997, 15:663-667.
95. Heikoop J.C., van Beuningen de Vaan M., van den Boogaart P., et al. Evaluation of subunit truncation and the nature of the spacer for single chain human gonadotropins. Eur J Biochem 1997, 245:656-662.
96. Heikoop J.C., van den Boogaart P., Mulders J.W.M., et al. Structure-based design and protein engineering of intersubunit disulfide bonds in gonadotropins. Nat Biotechnol 1997, 15:658-662.
97. Heikoop J.C., Huisman-de Winkel B., Grootenhuis P.D.J. Towards minimized gonadotropins with full bioactivity. Eur J Biochem 1999, 261:81-83.
98. Ben-Menahem D., Jablonka-Shariff A., Hyde R., et al. The orientation of the gonadotropin alpha and beta domains in a single chain affects the heterodimeric interaction of the subunits. Biol Reprod 1999, 60. 274-274.
99. Ben-Menahem D., Jablonka-Shariff A., Hyde R.K., et al. The position of the alpha and beta subunits in a single chain variant of human chorionic gonadotropin affects the heterodimeric interaction of the subunits and receptor-binding epitopes. J Biol Chem 2001, 276:29871-29879.
100. Narayan P., Gray J., Puett D. A biologically active single chain human chorionic gonadotropin analog with altered receptor binding properties. Endocrinology 2000, 141:67-71.
101. Narayan P., Wu C.B., Puett D. Genetic engineering of single-chain gonadotropins and hormone-receptor fusion proteins. Methods 2000, 21:59-66.
102. Sen Gupta C., Dighe R.R. Biological activity of single chain chorionic gonadotropin, hCG alpha beta, is decreased upon deletion of five carboxyl terminal amino acids of the alpha subunit without affecting its receptor binding. J Mol Endocrinol 2000, 24:157-164.
103. Galet C., Chopineau M., Martinat N., et al. Expression of an in vitro biologically active equine LH/CG without c-terminal peptide (CTP) and/or beta 26-110 disulphide bridge. J Endocrinol 2000, 167:117-124.
104. Fralish G.B., Dattilo B., Puett D. Structural analysis of yoked chorionic gonadotropin-luteinizing hormone receptor ectodomain complexes by circular dichroic spectroscopy. Mol Endocrinol 2003, 17:1192-1202.
105. Fralish G.B., Narayan P., Puett D. Consequences of single-chain translation on the structures of two chorionic gonadotropin yoked analogs in alpha-beta and beta-alpha configurations. Mol Endocrinol 2003, 17:757-767.
106. Setlur S.R., Dighe R.R. Single chain human chorionic gonadotropin, hCG alpha beta: effects of mutations in the alpha subunit on structure and bioactivity. Glycoconj J 2007, 24:97-106.
107. Ben Menahem D., Kudo M., Pixley M.B., et al. The biologic action of single-chain choriogonadotropin is not dependent on the individual disulfide bonds of the beta subunit. J Biol Chem 1997, 272:6827-6830.
108. Sato A., Perlas E., Ben Menahem D., et al. Cystine knot of the gonadotropin alpha subunit is critical for intracellular behavior but not for in vitro biological activity. J Biol Chem 1997, 272:18098-18103.
109. Jablonka-Shariff A., Kumar T.R., Eklund J., et al. Single-chain, triple-domain gonadotropin analogs with disulfide bond mutations in the alpha-subunit elicit dual follitropin and lutropin activities in vivo. Mol Endocrinol 2006, 20:1437-1446.
110. Heikoop J.C., Van Den Boogaart P., De Leeuw R., et al. Partially deglycosylated human choriogonadotropin, stabilized by intersubunit disulfide bonds, shows full bioactivity. Eur J Biochem 1998, 253:354-356.
111. Einstein M., Lin W., Macdonald G.J., et al. Partial restoration of lutropin activity by an intersubunit disulfide bond: implications for structure/function studies. Exp Biol Med 2001, 226:581-590.
112. Bernard M.P., Lin W., Myers R., et al. Crosslinked bifunctional gonadotropin analogs with reduced efficacy. Mol Cell Endocrinol 2005, 233:25-31.
113. Kanda M., Jablonka-Shariff A., Sato A., et al. Genetic fusion of an alpha-subunit gene to the follicle-stimulating hormone and chorionic gonadotropin-beta subunit genes: production of a bifunctional protein. Mol Endocrinol 1999, 13:1873-1881.
114. Garcia-Campayo V., Boime I. Independent activities of FSH and LH structurally confined in a single polypeptide: selective modification of the relative potencies of the hormones. Endocrinology 2001, 142:5203-5211.
115. Jablonka-Shariff A., Comstock A., Colgin M., et al. Construction and expression of an ovine single chain triple-domain chimeric gonadotropin: tandem linkage of the genes encoding the alpha- and FSH beta and LH beta subunits. Biol Reprod 2007, 131-132.
116. Garcia-Campayo V., Jablonka-Shariff A., Boime I. A single-chain bifunctional gonadotropin analog is secreted from Chinese hamster ovary cells as two distinct bioactive species. J Biol Chem 2004, 279:44286-44293.
117. Garcia-Campayo V., Kumar T.R., Boime I. Thyrotropin, follitropin, and chorionic gonadotropin expressed as a single multifunctional unit reveal remarkable permissiveness in receptor-ligand interactions. Endocrinology 2002, 143:3773-3778.
118. Garcia-Campayo V., Boime I., Ma X.P., et al. A single-chain tetradomain glycoprotein hormone analog elicits multiple hormone activities in vivo. Biol Reprod 2005, 72:301-308.
119. Wu C.B., Narayan P., Puett D. Protein engineering of a novel constitutively active hormone-receptor complex. J Biol Chem 1996, 271:31638-31642.
120. Puett D., Wu C.B., Narayan P. The tie that binds: design of biologically active single-chain human chorionic gonadotropins and a gonadotropin-receptor complex using protein engineering. Biol Reprod 1998, 58:1337-1342.
121. Meehan T.P., Harmon B.G., Overcast M.E., et al. Gonadal defects and hormonal alterations in transgenic mice expressing a single chain human chorionic gonadotropin-lutropin receptor complex. J Mol Endocrinol 2005, 34:489-503.
122. Narayan P., Gray J., Puett D. Yoked complexes of human choriogonadotropin and the lutropin receptor: evidence that monomeric individual subunits are inactive. Mol Endocrinol 2002, 16:2733-2745.
123. Boorstein W.R., Vamvakopoulos N.C., Fiddes J.C. Human chorionic-gonadotropin beta-subunit is encoded by at least eight genes arranged in tandem and inverted pairs. Nature 1982, 300:419-422.
124. Policastro P.F., Daniels-McQueen S., Carle G., et al. A map of the hCG-beta-LH-beta gene-cluster. J Biol Chem 1986, 261:5907-5916.
125. Li M.D., Ford J.J. A comprehensive evolutionary analysis based on nucleotide and amino acid sequences of the alpha- and beta-subunitsof glycoprotein hormone gene family. J Endocrinol 1998, 156:529-542.
126. Talmadge K., Boorstein W.R., Fiddes J.C. The human genome contains 7 genes for the beta-subunit of chorionic-gonadotropin but only one gene for the beta-subunit of luteinizing-hormone. DNA Cell Biol 1983, 2:281-289.
127. Talmadge K., Boorstein W.R., Vamvakopoulos N.C., et al. Only 3 of the 7 human chorionic-gonadotropin beta-subunit genes can be expressed in the placenta. Nucleic Acids Res 1984, 12:8415-8436.
128. Rull K., Laan M. Expression of beta-subunit of HCG genes during normal and failed pregnancy. Hum Reprod 2005, 20:3360-3368.
129. Hallast P., Nagirnaja L., Margus T., et al. Segmental duplications and gene conversion: human luteinizing hormone/chorionic gonadotropin beta gene cluster. Genome Res 2005, 15:1535-1546.
130. Hallast P., Rull K., Laan M. The evolution and genomic landscape of CGB1 and CGB2 genes. Mol Cell Endocrinol 2007, 260:2-11.
131. Bo M., Boime I. Identification of the transcriptionally active genes of the chorionic gonadotropin-beta gene-cluster invivo. J Biol Chem 1992, 267:3179-3184.
132. Miller Lindholm A.K., LaBenz C.J., Ramey J., et al. Human chorionic gonadotropin-beta gene expression in first trimester placenta. Endocrinology 1997, 138:5459-5465.
133. Delegeane A.M., Ferland L.H., Mellon P.L. Tissue-specific enhancer of the human glycoprotein hormone alpha-subunit gene: dependence on cyclic amp-inducible elements. Mol Cell Biol 1987, 7:3994-4002.
134. Jameson J.L., Fuh V.L., Burrin J.M. Cyclic-amp effects on chorionic-gonadotropin alpha-subunit and beta-subunit gene-transcription and messenger-RNA stability. Clin Res 1989, 37. A359-A359.
135. Schoderbek W.E., Kim K.E., Ridgway E.C., et al. Analysis of DNA-sequences required for pituitary-specific expression of the glycoprotein hormone alpha-subunit gene. Mol Endocrinol 1992, 6:893-903.
136. Schoderbek W.E., Roberson M.S., Maurer R.A. 2 different DNA elements mediate gonadotropin-releasing-hormone effects on expression of the glycoprotein hormone alpha-subunit gene. J Biol Chem 1993, 268:3903-3910.
137. Barnhart K.M., Mellon P.L. The orphan nuclear receptor, steroidogenic factor-I, regulates the glycoprotein hormone alpha-subunit gene in pituitary gonadotropes. Mol Endocrinol 1994, 8:878-885.
138. Albanese C., Colin I.M., Crowley W.F., et al. The gonadotropin genes: evolution of distinct mechanisms for hormonal control. Recent Prog Horm Res 1996, 51:23-61.
139. Fowkes R.C., King P., Burrin J.M. Regulation of human glycoprotein hormone alpha-subunit gene transcription in LβT2 gonadotropes by protein kinase c and extracellular signal-regulated kinase 1/2. Biol Reprod 2002, 67:725-734.
140. Fowkes R.C., Desclozeaux M., Patel M.V., et al. Steroidogenic factor-1 and the gonadotrope-specific element enhance basal and pituitary adenylate cyclase-activating polypeptide-stimulated transcription of the human glycoprotein hormone alpha-subunit gene in gonadotropes. Mol Endocrinol 2003, 17:2177-2188.
141. Boime I., Garcia-Campayo V., Hsueh A.J.W. The glycoprotein hormones and their receptors. Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management 2004, 75-92. Saunders, Philadelphia. J. Strauss, R.L. Barbieri (Eds.).
142. Hollenberg A.N., Pestell R.G., Albanese C., et al. Multiple promoter elements in the human chorionic-gonadotropin beta-subunit genes distinguish their expression from the luteinizing-hormone beta-gene. Mol Cell Endocrinol 1994, 106:111-119.
143. Knofler M., Saleh L., Bauer S., et al. Transcriptional regulation of the human chorionic gonadotropin beta gene during villous trophoblast differentiation. Endocrinology 2004, 145:1685-1694.
144. Gharib S.D., Wierman M.E., Shupnik M.A., et al. Molecular-biology of the pituitary gonadotropins. Endocr Rev 1990, 11:177-199.
145. Laan M., Wiebe V., Khusnutdinova E., et al. X-chromosome as a marker for population history: linkage disequilibrium and haplotype study in Eurasian populations. Eur J Hum Genet 2005, 13:452-462.
146. Dirnhofer S., Hermann M., Hittmair A., et al. Expression of the human chorionic gonadotropin-beta gene cluster in human pituitaries and alternate use of exon 1. J Clin Endocrinol Metab 1996, 81:4212-4217.
147. Berger P., Kranewitter W., Madersbacher S., et al. Eutopic production of human chorionic-gonadotropin-beta (hCG-beta) and luteinizing-hormone-beta (hLH-beta) in the human testis. FEBS Lett 1994, 343:229-233.
148. Giovangrandi Y., Parfait B., Asheuer M., et al. Analysis of the human CGB/LHB gene cluster in breast tumors by real-time quantitative RT-PCR assays. Cancer Lett 2001, 168:93-100.
149. Strauss B.L., Pittman R., Pixley M.R., et al. Expression of the beta-subunit of chorionic-gonadotropin in transgenic mice. J Biol Chem 1994, 269:4968-4973.
150. Nishimura R., Shin J., Ji I., et al. A single amino acid substitution in an ectopic alpha subunit of a human carcinoma choriogonadotropin. J Biol Chem 1986, 261:10475-10477.
151. Jameson J.L. Inherited disorders of the gonadotropin hormones. Mol Cell Endocrinol 1996, 125:143-149.
152. Layman L.C. Human gene mutations causing infertility. J Med Genet 2002, 39:153-161.
153. Layman L.C., Porto A.L.A., Xie J., et al. FSH beta gene mutations in a female with partial breast development and a male sibling with normal puberty and azoospermia. J Clin Endocrinol Metab 2002, 87:3702-3707.
154. Huhtaniemi I., Jiang M., Nilsson C., et al. Mutations and polymorphisms in gonadotropin genes. Mol Cell Endocrinol 1999, 151:89-94.
155. Huhtaniemi I.T., Themmen A.P.N. Mutations in human gonadotropin and gonadotropin-receptor genes. Endocrine 2005, 26:207-217.
156. Achermann J.C., Ozisik G., Meeks J.J., et al. Genetic causes of human reproductive disease. J Clin Endocrinol Metab 2002, 87:2447-2454.
157. Themmen A.P.N. An update of the pathophysiology of human gonadotrophin subunit and receptor gene mutations and polymorphisms. Reproduction 2005, 130:263-274.
158. Bhagavath B., Layman L.C. The genetics of hypogonadotropic hypogonadism. Semin Reprod Med 2007, 25:272-285.
159. Weiss J., Axelrod L., Whitcomb R.W., et al. Hypogonadism caused by a single amino-acid substitution in the beta subunit of luteinizing-hormone. N Engl J Med 1992, 326:179-183.
160. Valdes-Socin H., Salvi R., Daly A.F., et al. Brief report: hypogonadism in a patient with a mutation in the luteinizing hormone beta-subunit gene. N Engl J Med 2004, 351:2619-2625.
161. Lofrano-Porto A., Barra G.B., Giacomini L.A., et al. Luteinizing hormone beta mutation and hypogonadism in men and women. N Engl J Med 2007, 357:897-904.
162. Matthews C.H., Borgato S., Beckpeccoz P., et al. Primary amenorrhea and infertility due to a mutation in the beta-subunit of follicle-stimulating-hormone. Nat Genet 1993, 5:83-86.
163. Phillip M., Arbelle J.E., Segev Y., et al. Male hypogonadism due to a mutation in the gene for the beta-subunit of follicle-stimulating hormone. N Engl J Med 1998, 338:1729-1732.
164. Layman L.C., Lee E.J., Peak D.B., et al. Delayed puberty and hypogonadism caused by mutations in the follicle-stimulating hormone beta-subunit gene. N Engl J Med 1997, 337:607-611.
165. Lindstedt G., Nystrom E., Matthews C., et al. Follitropin (FSH) deficiency in an infertile male due to FSH beta gene mutation: a syndrome of normal puberty and virilization but underdeveloped testicles with azoospermia, low FSH but high lutropin and normal serum testosterone concentrations. Clin Chem Lab Med 1998, 36:663-665.
166. Keir G., Winchester B.G., Clayton P. Carbohydrate-deficient glycoprotein syndromes: inborn errors of protein glycosylation. Ann Clin Biochem 1999, 36:20-36.
167. Furui K., Suganuma N., Tsukahara S., et al. Identification of 2 point mutations in the gene coding luteinizing-hormone (LH) beta-subunit, associated with immunologically anomalous LH variants. J Clin Endocrinol Metab 1994, 78:107-113.
168. Suganuma N., Furui K., Furuhashi M., et al. Screening of the mutations in luteinizing-hormone beta-subunit in patients with menstrual disorders. Fertil Steril 1995, 63:989-995.
169. Suganuma N., Furui K., Kikkawa F., et al. Effects of the mutations (Trp(8)>Arg and Ile(15);Thr) in human luteinizing hormone (LH) beta-subunit on LH bioactivity in vitro and in vivo. Endocrinology 1996, 137:831-838.
170. Nilsson C., Pettersson K., Millar R.P., et al. Worldwide frequency of a common genetic variant of luteinizing hormone: an international collaborative research. Fertil Steril 1997, 67:998-1004.
171. Nilsson C., Jiang M., Pettersson K., et al. Determination of a common genetic variant of luteinizing hormone using DNA hybridization and immunoassays. Clin Endocrinol 1998, 49:369-376.
172. Jiang M., Pakarainen P., Zhang F.P., et al. A common polymorphic allele of the human luteinizing hormone beta-subunit gene: additional mutations and differential function of the promoter sequence. Hum Mol Genet 1999, 8:2037-2046.
173. Lamminen T., Huhtaniemi I. A common variant of luteinizing hormone: relation to normal and aberrant pituitary-gonadal function. Eur J Pharmacol 2001, 414:1-7.
174. Ramanujam L.N., Liao W.X., Roy A.C., et al. Association of molecular variants of luteinizing hormone with male infertility. Hum Reprod 2000, 15:925-928.
175. Cramer D.W., Petterson K.S.I., Barbieri R.L., et al. Reproductive hormones, cancers, and conditions in relation to a common genetic variant of luteinizing hormone. Hum Reprod 2000, 15:2103-2107.
176. Takahashi K., Kurioka H., Ozaki T., et al. Pituitary response to luteinizing hormone-releasing hormone in women with variant luteinizing hormone. Eur J Endocrinol 2000, 143:375-381.
177. Lee S., Kim N.K., Kim H.J., et al. Genetic analysis of three polymorphic sites of the luteinizing hormone beta-subunit gene in infertile Korean men with nonbstructive azoospermia. Fertil Steril 2003, 79:517-521.
178. Powell B.L., Piersma D., Kevenaar M.E., et al. Luteinizing hormone signaling and breast cancer: polymorphisms and age of onset. J Clin Endocrinol Metab 2003, 88:1653-1657.
179. Manna P.R., Joshi L., Reinhold V.N., et al. Synthesis, purification and structural and functional characterization of recombinant form of a common genetic variant of human luteinizing hormone. Hum Mol Genet 2002, 11:301-315.
180. Roy A.C., Liao W.X., Chen Y., et al. Identification of seven novel mutations in LH beta-subunit gene by SSCP. Mol Cell Biochem 1996, 165:151-153.
181. Liao W.X., Roy A.C., Chan C., et al. A new molecular variant of luteinizing hormone associated with female infertility. Fertil Steril 1998, 69:102-106.
182. Ramanujam L., Liao W.X., Roy A.C., et al. Molecular variants of luteinizing hormone in three populations of southeast Asia. Hum Hered 1998, 48:232-234.
183. Lamminen T., Jiang M., Manna P.R., et al. Functional study of a recombinant form of human LH beta-subunit variant carrying the Gly(102)Ser mutation found in asian populations. Mol Hum Reprod 2002, 8:887-892.
184. Liao W.X., Goh H.H., Roy A.C. Functional characterization of a natural variant of luteinizing hormone. Hum Genet 2002, 111:219-224.
185. Jiang M., Lamminen T., Pakarinen P., et al. A novel Ala(-3)Thr mutation in the signal peptide of human luteinizing hormone beta-subunit: potentiation of the inositol phosphate signalling pathway and attenuation of the adenylate cyclase pathway by recombinant variant hormone. Mol Hum Reprod 2002, 8:201-212.
186. Miller-Lindholm A.K., Bedows E., Bartels C.F., et al. A naturally occurring genetic variant in the human chorionic gonadotropin-beta gene 5 is assembly inefficient. Endocrinology 1999, 140:3496-3506.
187. Jiang M., Savontaus M.L., Simonsen H., et al. Absence of the genetic variant val(79)met in human chorionic gonadotropin-beta gene 5 in five European populations. Mol Human Reprod 2004, 10:763-766.
188. Layman L.C. Genetics of human hypogonadotropic hypogonadism. Am J Med Genet 1999, 89:240-248.
189. Tena-Sempere M. Kiss-1 and reproduction: focus on its role in the metabolic regulation of fertility. Neuroendocrinology 2006, 83:275-281.
190. Smith J.T., Clarke I.J. Kisspeptin expression in the brain: catalyst for the initiation of puberty. Rev Endocr Metab Disord 2007, 8:1-9.
191. Navarro V.M., Castellano J.M., Garcia-Galiano D., et al. Neuroendocrine factors in the initiation of puberty: the emergent role of kisspeptin. Rev Endocr Metab Disord 2007, 8:11-20.
192. Ferris H.A., Shupnik M.A. Mechanisms for pulsatile regulation of the gonadotropin subunit genes by GNRH1. Biol Reprod 2006, 74:993-998.
193. Jorgensen J.S., Quirk C.C., Nilson J.H. Multiple and overlapping combinatorial codes orchestrate hormonal responsiveness and dictate cell-specific expression of the genes encoding luteinizing hormone. Endocr Rev 2004, 25:521-542.
194. Burger L.L., Haisenleder D.J., Dalkin A.C., et al. Regulation of gonadotropin subunit gene transcription. J Mol Endocrinol 2004, 33:559-584.
195. Burger L.L., Haisenleder D.J., Wotton G.M., et al. The regulation of FSH beta transcription by gonadal steroids: testosterone and estradiol modulation of the activin intracellular signaling pathway. Am J Physiol Endocrinol Metab 2007, 293:E277-E285.
196. Melamed P., Kadir M.N.A., Wijeweera A., et al. Transcription of gonadotropin beta subunit genes involves cross-talk between the transcription factors and co-regulators that mediate actions of the regulatory hormones. Mol Cell Endocrinol 2006, 252:167-183.
197. Heckert L.L., Schultz K., Nilson J.H. Different composite regulatory elements direct expression of the human alpha-subunit gene to pituitary and placenta. J Biol Chem 1995, 270:26497-26504.
198. Salisbury T.B., Binder A.K., Grammer J.C., et al. Maximal activity of the luteinizing hormone beta-subunit gene requires beta-catenin. Mol Endocrinol 2007, 21:963-971.
199. Bailey J.S., Rave-Harel N., McGillivray S.M., et al. Activin regulation of the follicle-stimulating hormone beta-subunit gene involves smads and the tale homeodomain proteins pbx1 and prep1. Mol Endocrinol 2004, 18:1158-1170.
200. Jameson J.L., Hollenberg A.N. Regulation of chorionic-gonadotropin gene-expression. Endocr Rev 1993, 14:203-221.
201. Steger D.J., Buscher M., Hecht J.H., et al. Coordinate control of the alpha-subunit and beta-subunit genes of human chorionic-gonadotropin by trophoblast specific element-binding protein. Mol Endocrinol 1993, 7:1579-1588.
202. Ghosh D., Sachdev S., Hannick M., et al. Coordinate regulation of basal and cyclic 5́-adenosine monophosphate (cAMP)-activated expression of human chorionic gonadotropin-alpha by ets-2 and cAMP-responsive element binding protein. Mol Endocrinol 2005, 19:1049-1066.
203. Wide L., Lee J.Y., Rasmussen C. A change in the isoforms of human chorionic-gonadotropin occurs around the 13th week of gestation. J Clin Endocrinol Metab 1994, 78:1419-1423.
204. Kovalevskaya G., Birken S., Kakuma T., et al. Early pregnancy human chorionic gonadotropin (hCG) isoforms measured by an immunometric assay for choriocarcinoma-like hCG. J Endocrinol 1999, 161:99-106.
205. Kovalevskaya G., Genbacev O., Fisher S.J., et al. Trophoblast origin of hCG isoforms: cytotrophoblasts are the primary source of choriocarcinoma-like hCG. Mol Cell Endocrinol 2002, 194:147-155.
206. Birken S., McChesney R., Yershova O., et al. Patterns of LH beta cf among women in health and disease. Mol Cell Endocrinol 2007, 260:172-182.
207. Kelly L.S., Birken S., Puett D. Determination of hyperglycosylated human chorionic gonadotropin produced by malignant gestational trophoblastic neoplasias and male germ cell tumors using a lectin-based immunoassay and surface plasmon resonance. Mol Cell Endocrinol 2007, 260:33-39.
208. Keel B.A., Grotjan H.E. Luteinizing hormone microheterogeneity. Microheterogeneity of Glycoprotein Hormones 1989, 149-184. CRC Press, Boca Raton, FL. B.A. Keel, H.E. Grotjan (Eds.).
209. Baenziger J.U. Protein-specific glycosyltransferases: how and why they do it. FASEB J 1994, 8:1019-1025.
210. Elliott M.M., Kardana A., Lustbader J.W., et al. Carbohydrate and peptide structure of the alpha -and beta-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma. Endocrine 1997, 7:15-32.
211. Cole L.A., Khanlian S.A., Riley J.M., et al. Hyperglycosylated hCG in gestational implantation and in choriocarcinoma and testicular germ cell malignancy tumorigenesis. J Reprod Med 2006, 51:919-928.
212. Kovalevskaya G., Kakuma T., Schlatterer J., et al. Hyperglycosylated HCG expression in pregnancy: cellular origin and clinical applications. Mol Cell Endocrinol 2007, 260:237-243.
213. Kessler M.J., Reddy M.S., Shah R.H., et al. Structures of n-glycosidic carbohydrate units of human chorionic-gonadotropin. J Biol Chem 1979, 254:7901-7908.
214. Weisshaar G., Hiyama J., Renwick A.G.C., et al. NMR investigations of the N-linked oligosaccharides at individual glycosylation sites of human lutropin. Eur J Biochem 1991, 195:257-268.
215. Iles R.K., Wathen N.C., Campbell D.J., et al. Human chorionic-gonadotropin and subunit composition of maternal serum and celomic and amniotic fluids in the 1st trimester of pregnancy. J Endocrinol 1992, 135:563-569.
216. Jablonka-Shariff A., Pearl C.A., Comstock A., Boime I. A carboxyl-terminal sequence in the lutropin β subunit contributes to the sorting of lutropin to the regulated pathway. J Biol Chem 2008, 283:11485-11492.
217. Jablonka-Shariff A., Garcia-Campayo V., Boime I. Evolution of lutropin to chorionic gonadotropin generates a specific routing signal for apical release in vivo. J Biol Chem 2002, 277:879-882.
218. Jablonka-Shariff A., Daphna-Iken D., Boime I. Role of the LH beta carboxyl terminus in the secretion and assembly with the alpha subunit in pituitary-derived gh3 cells. Biol Reprod 2004, 175-175.
219. Green E.D., Boime I., Baenziger J.U. Biosynthesis of sulfated asparagine-linked oligosaccharides on bovine lutropin. J Biol Chem 1986, 261:6309-6316.
220. Green E.D., Baenziger J.U. Asparagine-linked oligosaccharides on lutropin, follitropin, and thyrotropin: 1. Structural elucidation of the sulfated and sialylated oligosaccharides on bovine, ovine, and human pituitary glycoprotein hormones. J Biol Chem 1988, 263:25-35.
221. Green E.D., Baenziger J.U. Asparagine-linked oligosaccharides on lutropin, follitropin, and thyrotropin: 2. Distributions of sulfated and sialylated oligosaccharides on bovine, ovine, and human pituitary glycoprotein hormones. J Biol Chem 1988, 263:36-44.
222. Reisinger K., Baal N., McKinnon T., et al. The gonadotropins: tissue-specific angiogenic factors?. Mol Cell Endocrinol 2007, 269:65-80.
223. Birken S., Maydelman Y., Gawinowicz M.A., et al. Isolation and characterization of human pituitary chorionic gonadotropin. Endocrinology 1996, 137:1402-1411.
224. Amr S., Rosa C., Wehmann R., et al. Unusual molecular-forms of HCG in gestational trophoblastic neoplasia. Ann Endocrinol (Paris) 1984, 45:321-326.
225. Amano J., Nishimura R., Mochizuki M., et al. Comparative study of the mucin-type sugar chains of human chorionic-gonadotropin present in the urine of patients with trophoblastic diseases and healthy pregnant women. J Biol Chem 1988, 263:1157-1165.
226. Mitchell H., Seckl M.J. Discrepancies between commercially available immunoassays in the detection of tumour-derived hCG. Mol Cell Endocrinol 2007, 260:310-313.
227. Madersbacher S., Gerth R., Mann K., et al. Gonadotrophin secretion patterns in testicular cancer patients with greatly increased human chorionic gonadotrophin serum concentrations. J Endocrinol 1998, 159:451-458.
228. Stenman U.H., Alfthan H., Hotakainen K. Human chorionic gonadotropin in cancer. Clin Biochem 2004, 37:549-561.
229. Iles R.K. Ectopic hCG beta expression by epithelial cancer: malignant behaviour, metastasis and inhibition of tumor cell apoptosis. Mol Cell Endocrinol 2007, 260:264-270.
230. Bieche I., Parfait B., Nogues C., et al. The CGA gene as new predictor of the response to endocrine therapy in ER alpha-positive postmenopausal breast cancer patients. Oncogene 2001, 20:6955-6959.
231. Bieche I., Latil A., Parfait B., et al. CGA gene (coding for the alpha subunit of glycoprotein hormones) overexpression in ER alpha-positive prostate tumors. Eur Urol 2002, 41:335-341.
232. Bieche I., Lazar V., Nogues C., et al. Prognostic value of chorionic gonadotropin beta gene transcripts in human breast carcinoma. Clin Cancer Res 1998, 4:671-676.
233. Cole L.A., Shahabi S., Oz U.A., et al. Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: a new basis for gestational Down syndrome screening. Clin Chem 1999, 45:2109-2119.
234. Pandian R., Cole L.A., Palomaki G.E. Second-trimester maternal serum invasive trophoblast antigen: a marker for Down syndrome screening. Clin Chem 2004, 50:1433-1435.
235. Bahado-Singh R.O., Oz U., Shahabi S., et al. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies. Am J Obstet Gynecol 2000, 183:1114-1118.
236. Sturgeon C.M., Ellis A.R. Standardization of FSH, LH and hCG: current position and future prospects. Mol Cell Endocrinol 2007, 260:301-309.
237. Birken S., Kovalevskaya G., O'Connor J. Immunochemical measurement of early pregnancy isoforms of hCG: potential applications to fertility research, prenatal diagnosis, and cancer. Arch Med Res 2001, 32:635-643.
238. Berger P., Sturgeon C., Bidart J.M., et al. The isobm td-7 workshop on hCG and related molecules: towards user-oriented standardization of pregnancy and tumor diagnosis. Assignment of epitopes to the three-dimensional structure of diagnostically and commercially relevant monoclonal antibodies directed against human chorionic gonadotropin and derivatives. Tumor Biol 2002, 23:1-38.
239. Bristow A., Berger P., Bidart J.M., et al. Establishment, value assignment, and characterization of new WHO reference reagents for six molecular forms of human chorionic gonadotropin. Clin Chem 2005, 51:177-182.
240. Fares F.A., Suganuma N., Nishimori K., et al. Design of a long-acting follitropin agonist by fusing the c-terminal sequence of the chorionic-gonadotropin beta-subunit to the follitropin beta-subunit. Proc Natl Acad Sci U S A 1992, 89:4304-4308.
241. Lapolt P.S., Nishimori K., Fares F.A., et al. Enhanced stimulation of follicle maturation and ovulatory potential by long-acting follicle-stimulating-hormone agonists with extended carboxyl-terminal peptides. Endocrinology 1992, 131:2514-2520.
242. Bouloux P.M.G., Handelsman D.J., Jockenhovel F., et al. First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males. Hum Reprod 2001, 16:1592-1597.
243. Duijkers I.J.M., Klipping C., Boerrigter P.J., et al. Single dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females. Hum Reprod 2002, 17:1987-1993.
244. Adams T.E., Boime I. The expanding role of recombinant gonadotropins in assisted reproduction. Reprod Dom Animals 2008, 186-192.
245. Perlman S., van den Hazel B., Christiansen J., et al. Glycosylation of an N-terminal extension prolongs the half-life and increases the in vivo activity of follicle stimulating hormone. J Clin Endocrinol Metab 2003, 88:3227-3235.
246. Janssens J.P., Russo J., Irma R.D., et al. Human chorionic gonadotropin (hCG) and prevention of breast cancer. Mol Cell Endocrinol 2007, 269:93-98.
247. Keri R.A., Lozada K.L., Abdul-Karim F.W., et al. Luteinizing hormone induction of ovarian tumors: oligogenic differences between mouse strains dictates tumor disposition. Proc Natl Acad Sci U S A 2000, 97:383-387.
248. Rulli S.B., Kuorelahti A., Karaer O., et al. Reproductive disturbances, pituitary lactotrope adenomas, and mammary gland tumors in transgenic female mice producing high levels of human chorionic gonadotropin. Endocrinology 2002, 143:4084-4095.
249. Rulli S.B., Huhtaniemi I. What have gonadotrophin overexpressing transgenic mice taught us about gonadal function?. Reproduction 2005, 130:283-291.
250. Matzuk M.M., DeMayo F.J., Hadsell L.A., et al. Overexpression of human chorionic gonadotropin causes multiple reproductive defects in transgenic mice. Biol Reprod 2003, 69:338-346.
251. Mikola M., Kero J., Nilson J.H., et al. High levels of luteinizing hormone analog stimulate gonadal and adrenal tumorigenesis in mice transgenic for the mouse inhibin-alpha-subunit promoter simian virus 40 t-antigen fusion gene. Oncogene 2003, 22:3269-3278.
252. Hansel W., Enright F., Leuschner C. Destruction of breast cancers and their metastases by lytic peptide conjugates in vitro and in vivo. Mol Cell Endocrinol 2007, 260. 183-189.
253. Leuschner C., Enright F.M., Gawronska B., et al. Membrane disrupting lytic peptide conjugates destroy hormone dependent and independent breast cancer cells in vitro and in vivo. Breast Cancer Res Treat 2003, 78:17-27.
254. Gawronska B., Leuschner C., Enright F.M., et al. Effects of a lytic peptide conjugated to beta hCG on ovarian cancer: studies in vitro and in vivo. Gynecol Oncol 2002, 85:45-52.
255. Hansel W., Leuschner C., Enright F. Conjugates of lytic peptides and LHRH or PCG target and cause necrosis of prostate cancers and metastases. Mol Cell Endocrinol 2007, 269:26-33.
256. Rivero-Muller A., Vuorenoja S., Tuominen M., et al. Use of hecate-chorionic gonadotropin beta conjugate in therapy of lutenizing hormone receptor expressing gonadal somatic cell tumors. Mol Cell Endocrinol 2007, 269:17-25.
257. Lunardi Iskandar Y., Bryant J.L., Zeman R.A., et al. Human chorionic gonadotropin (hCG) induces apoptosis of neoplastic Kaposi's sarcoma cell lines (ks y-1 and ks slk). Blood 1995, 86. 1514-1514.
258. Samaniego F., Bryant J.L., Liu N., et al. Induction of programmed cell death in Kaposi's sarcoma cells by preparations of human chorionic gonadotropin. J Natl Cancer Inst 1999, 91:135-143.
259. Pfeffer U., Bisacchi D., Morini M., et al. Human chorionic gonadotropin inhibits Kaposi's sarcoma associated angiogenesis, matrix metalloprotease activity, and tumor growth. Endocrinology 2002, 143:3114-3121.
260. Casadesus G., Webber K.M., Atwood C.S., et al. Luteinizing hormone modulates cognition and amyloid-deposition in Alzheimer APP transgenic mice. Biochim Biophys Acta 2006, 1762:447-452.
261. Casadesus G., Milliken E.L., Webber K.M., et al. Increases in luteinizing hormone are associated with declines in cognitive performance. Mol Cell Endocrinol 2007, 269:107-111.
262. Webber K.M., Casadesus G., Atwood C.S., et al. Gonadotropins: a cohesive gender-based etiology of Alzheimer disease. Mol Cell Endocrinol 2007, 260:271-275.
263. Minegishi T., Nakamura K., Takakura Y., et al. Cloning and sequencing of human LH/hCG receptor cDNA. Biochem Biophys Res Commun 1990, 172:1049-1054.
264. Jia X.-C., Oikawa M., Bo M., et al. Expression of human luteinizing hormone (LH) receptor: interaction with LH and chorionic gonadotropin from human but not equine, rat, and ovine species. Mol Endocrinol 1991, 5:759-768.
265. Minegishi T., Nakamura K., Takakura Y., et al. Cloning and sequencing of human FSH receptor cDNA. Biochem Biophys Res Commun 1991, 175:1125-1130.
266. Kelton C., Cheng S.V.Y., Nugent N.P., et al. The cloning of the human follicle stimulating hormone receptor and its expression in cos-7, cho, and y-1 cells. Mol Cell Endocrinol 1992, 89:141-151.
267. Gether U. Uncovering molecular mechanisms involved in activation of g protein-coupled receptors. Endocr Rev 2000, 21:90-113.
268. Vassilatis D.K., Hohmann J.G., Zeng H., et al. The G protein-coupled receptor repertoires of human and mouse. Proc Natl Acad Sci U S A 2003, 100:4903-4908.
269. Ballesteros J.A., Shi L., Javitch J.A. Structural mimicry in G protein coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. Mol Pharmacol 2001, 60:1-19.
270. Ascoli M., Fanelli F., Segaloff D.L. The lutropin/choriogonadotropin receptor: a 2002 perspective. Endocr Rev 2002, 23:141-174.
271. Sanders J., Chirgadze D.Y., Sanders P., et al. Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody. Thyroid 2007, 17:395-410.
272. Costagliola S., Panneels V., Bonomi M., et al. Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors. EMBO J 2002, 21:504-513.
273. Palczewski K., Kumasaka T., Hori T., et al. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 2000, 289:739-745.
274. Kleinau G., Brehm M., Wiedemann U., et al. Implications for molecular mechanisms of glycoprotein hormone receptors using a new sequence-structure-function analysis resource. Mol Endocrinol 2007, 21:574-580.
275. Van Durme J., Horn F., Costagliola S., et al. Gris: glycoprotein-hormone receptor information system. Mol Endocrinol 2006, 20:2247-2255.
276. Latronico A.C., Segaloff D.L. Insights learned from l457(3.43)r, an activating mutant of the human lutropin receptor. Mol Cell Endocrinol 2007, 260-262:287-293.
277. Jaschke H., Neumann S., Moore S., et al. A low molecular weight agonist signals by binding to the transmembrane domain of thyroid-stimulating hormone receptor (TSHR) and luteinizing hormone/chorionic gonadotropin receptor (LHCGR). J Biol Chem 2006, 281:9841-9844.
278. Heitman L., Oosterom J., Bonger K., et al. [3H]Org 43553, the first low molecular weight agonistic and allosteric radioligand for the human luteinizing hormone receptor. Mol Pharmacol 2008, 73:518-524.
279. Zhu H., Wang H., Ascoli M. The lutropin/choriogonadotropin (LH/CG) receptor is palmitoylated at intracellular cysteine residues. Mol Endocrinol 1995, 9:141-150.
280. Kawate N., Menon K.M.J. Palmitoylation of luteinizing hormone/human choriogonadotropin receptors in transfected cells. J Biol Chem 1994, 269:30651-30658.
281. Bradbury F.A., Kawate N., Foster C.M., et al. Post-translational processing in the Golgi plays a critical role in the trafficking of the luteinizing hormone/human chorionic gonadotropin receptor to the cell surface. J Biol Chem 1997, 272:5921-5926.
282. Munshi U.M., Clouser C.L., Peegel H., et al. Evidence that palmitoylation of carboxyl terminus cysteine residues of the human luteinizing hormone receptor regulates postendocytic processing. Mol Endocrinol 2005, 19:749-758.
283. Vu-Hai M.T., Huet J.C., Echasserieau K., et al. Posttranslational modifications of the lutropin receptor: mass spectrometric analysis. Biochemistry 2000, 39:5509-5517.
284. Davis D.P., Rozell T.G., Liu X., et al. The six N-linked carbohydraes of the lutropin/choriogonadotropin receptor are not absolutely required for correct folding, cell surface expression, hormone binding or signal transduction. Mol Endocrinol 1997, 11:550-562.
285. Zhang R., Cai H., Fatima N., et al. Functional glycosylation sites of the rat luteinizing hormone receptor required for ligand binding. J Biol Chem 1995, 270:21722-21728.
286. Davis D., Liu X., Segaloff D.L. Identification of the sites of N-linked glycosylation on the follicle-stimulating hormone (FSH) receptor and assesment of their role in FSH receptor function. Mol Endocrinol 1995, 9:159-170.
287. Tao Y.-X., Johnson N.B., Segaloff D.L. Constitutive and agonist-dependent self-association of the cell surface human lutropin receptor. J Biol Chem 2004, 279:5904-5914.
288. Vannier B., Loosfelt H., Meduri G., et al. Anti-human FSH receptor monoclonal antibodies: immunochemical and immunocytochemical characterization of the receptor. Biochemistry 1996, 35:1358-1366.
289. Quintana J., Hipkin R.W., Ascoli M. A polyclonal antibody to a synthetic peptide derived from the rat FSH receptor reveals the recombinant receptor as a 74 kda protein. Endocrinology 1993, 133:2098-2104.
290. Thomas R.M., Nechamen C.A., Mazurkiewicz J.E., et al. Follice-stimulating hormone receptor forms oligomers and shows evidence of carboxyl-terminal proteolytic processing. Endocrinology 2007, 148:1987-1995.
291. Tapanainen J.S., Bo M., Dunkel L., et al. Deglycosylation of the human luteinizing hormone receptor does not affect ligand binding and signal transduction. Endocrine 1993, 1:219-225.
292. Fabritz J., Ryan S., Ascoli M. Transfected cells express mostly the intracellular precursor of the lutropin/choriogonadotropin receptor but this precursor binds choriogonadotropin with high affinity. Biochemistry 1998, 37:664-672.
293. Abell A., Liu X., Segaloff D.L. Deletions of portions of the extracellular loops of the lutropin/choriogonadotropin receptor decrease the binding affinity for ovine luteinizing hormone, but not for human choriogonadotropin, by preventing the formation of mature cell surface receptor. J Biol Chem 1996, 271:4518-4527.
294. Rozell T.G., Wang H., Liu X., et al. Intracellular retention of mutant gonadotropin receptors results in loss of hormone binding activity of the follitropin receptor but not the lutropin/choriogonadotropin receptor. Mol Endocrinol 1995, 9:1727-1736.
295. Vu Hai-Luu Thi M.T., Jolivet A., Jallal B., et al. Monoclonal antibodies against luteinizing hormone receptor: immunochemical characterization of the receptor. Endocrinology 1990, 127:2090-2098.
296. Vu Hai-Luu Thi M.T., Misrahi M., Houillier A., et al. Variant forms of the pig lutropin/choriogonadotropin receptor. Biochemistry 1992, 31:8377-8383.
297. Hipkin R.W., Sánchez-Yagüe J., Ascoli M. Identification and characterization of a luteinizing hormone/chorionic gonadotropin (LH/CG) receptor precursor in a human kidney cell line stably transfected with the rat luteal LH/CG receptor complementary DNA. Mol Endocrinol 1992, 6:2210-2218.
298. Apaja P.M., Harju K.T., Aatsinki J.T., et al. Identification and structural characterization of the neuronal luteinizing hormone receptor associated with sensory systems. J Biol Chem 2004, 279:1899-1906.
299. Vassart G., Pardo L., Costagliola S. A molecular dissection of the glycoprotein hormone receptors. Trends Biochem Sci 2004, 29:119-126.
300. Costagliola S., Urizar E., Mendive F., et al. Specificity and promiscuity of gonadotropin receptors. Reproduction 2005, 130:275-281.
301. Hsu S.Y.T. New insights into the evolution of the relaxin-lgr signaling system. Trends Endocrinol Metab 2003, 14:303-309.
302. Hsu S.Y.T., Nakabayashi K., Nishi S., et al. Relaxin signaling in reproductive tissues. Mol Cell Endocrinol 2003, 202:165-170.
303. Bathgate R.A., Ivell R., Sanborn B.M., et al. International union of pharmacology: LVII. Recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol Rev 2006, 58:7-31.
304. Dufau M.L., Tsai-Morris C.H. The luteinizing hormone receptor. The Leydig Cell in Health and Disease 2007, 227-252. Humana Press, Totowa, NJ. A.H. Payne, M.P. Hardy (Eds.).
305. Herman B.P., Heckert L.L. Transcriptional regulation of the FSH receptor: new perspectives. Mol Cell Endocrinol 2007, 260-262:100-108.
306. Geng Y., Tsai-Morris C.H., Zhang Y., et al. The human luteinizing hormone receptor gene promoter: activation by sp1 and sp3 and inhibitory regulation. Biochem Biophys Res Commun 1999, 263:366-371.
307. Zhang Y., Dufau M.L. Nuclear orphan receptors regulate transcription of the gene for the human luteinizing hormone receptor. J Biol Chem 2000, 275:2763-2770.
308. Zhang Y., Dufau M. EAR2 and EAR3/COUP-TF1 regulate transcription of the rat LH receptor. Mol Endocrinol 2001, 15:1891-1905.
309. Youn H., Koo Y., Ji I., et al. An upstream initiator-like element suppresses transcription of the rat luteinizing hormone receptor gene. Mol Endocrinol 2005, 19:1318-1328.
310. Rahman N.A., Kiiveri S., Rivero-Muller A., et al. Adrenocortical tumorigenesis in transgenic mice expressing the inhibin α-subunit promoter/simian virus 40 t-antigen transgene: relationship between ectopic expression of luteinizing hormone receptor and transcription factor gata-4. Mol Endocrinol 2004, 18:2553-2569.
311. '-flanking region in transfected gonadal cells and in transgenic mice. Endocrinology 2001, 142:2427-2434.
312. Apaja P.M., Aatsinki J.T., Rajaniemi H.J., et al. Expression of the mature luteinizing hormone receptor in rodent urogenital and adrenal tissues is developmentally regulated at a posttranslational level. Endocrinology 2005, 146:3224-3232.
313. Linder C.C., Heckert L.L., Goetz T.L., et al. Follicle-stimulating hormone receptor gene promoter activity. Endocrine 1994, 2:957-966.
314. Griswold M.D. Kim J-S. Site-specific methylation of the promoter alters deoxyribonucleic acid-protein interactions and prevents follicle-stimulating hormone receptor gene transcription. Biol Reprod 2001, 64:602-610.
315. Heckert L.L., Griswold M.D. The expression of the follicle-stimulating hormone receptor in spermatogenesis. Recent Prog Horm Res 2002, 57:129-148.
316. Xing W., Ram Sairam M. Characterization of regulatory elements of ovine follicle-stimulating hormone (FSH) receptor gene: the role of e-box in the regulation of ovine FSH receptor expression. Biol Reprod 2001, 64:579-589.
317. Heckert L.L. Activation of the rat follicle-stimulating hormone receptor promoter by steroidogenic factor 1 is blocked by protein kinase a and requires upstream stimulatory factor binding to a proximal e box element. Mol Endocrinol 2001, 15:704-715.
318. Heckert L.L., Daggett M.A.F., Chen J. Multiple promoter elements contribute to activity of the follicle-stimulating hormone receptor (FSHR) gene in testicular Sertoli cells. Mol Endocrinol 1998, 12:1499-1512.
319. Heckert L.L., Daley I.J., Griswold M.D. Structural organization of the follicle-stimulating hormone receptor gene. Mol Endocrinol 1992, 6:70-80.
320. Hermann B.P., Hornbaker K.I., Maran R.R.M., et al. Distal regulatory elements are required for. fshr expression in vivo. Mol Cell Endocrinol 2007, 260-262:49-58.
321. Heckert L.L., Griswold M.D. Expression of follicle-stimulating hormone receptor mrna in rat testes and Sertoli cells. Mol Endocrinol 1991, 5:670-677.
322. Khan H., Yarney T.A., Sairam M.R. Cloning of alternately spliced mrna transcripts coding for variants of ovine testicular follitropin receptor lacking the G protein coupling domains. Biochem Biophys Res Commun 1993, 190:888-894.
323. Sairam M.R., Babu P.S. The tale of follitropin receptor diversity: a recipe for fine tuning gonadotropin responses?. Mol Cell Endocrinol 2007, 260-262:163-171.
324. Latronico A.C., Segaloff D.L. Naturally occurring mutations of the luteinizing-hormone receptor: lessons learned about reproductive physiology and G protein-coupled receptors. Am J Hum Genet 1999, 65:949-958.
325. Themmen A.P.N., Huhtaniemi I.T. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev 2000, 21:551-583.
326. Piersma D., Verhoef-Post M., Berns E.M.J.J., et al. LH receptor gene mutations and polymorphisms: an overview. Mol Cell Endocrinol 2007, 260-262:282-286.
327. Gromoll J., Eiholzer U., Nieschlag E., et al. Male hypogonadism caused by homozygous deletion of exon 10 of the luteinizing hormone (LH) receptor: differential action of human chorionic gonadotropin and LH. J Clin Endocrinol Metab 2000, 85:2281-2286.
328. Muller T., Gromoll J., Simoni M. Absence of exon 10 of the human luteinizing hormone (LH) receptor impairs LH, but not human chorionic gonadotropin action. J Clin Endocrinol Metab 2003, 88:2242-2249.
329. Muller T., Simoni M., Pekel E., et al. Chorionic gonadotrophin beta subunit mrna but not luteinising hormone beta subunit mrna is expressed in the pituitary of the common marmoset (. Callithrix jacchus). J Mol Endocrinol 2004, 32:115-128.
330. Zhang F.-P., Rannikko A.S., Manna P.R., et al. Cloning and functional expression of the luteinizing hormone receptor complementary deoxyribonucleic acid from the marmoset monkey testis: absence of sequences encoding exon 10 in other species. Endocrinology 1997, 138:2481-2490.
331. Gromoll J., Lahrmann L., Godmann M., et al. Genomic checkpoints for exon 10 usage in the luteinizing hormone receptor type 1 and type 2. Mol Endocrinol 2007, 21:1984-1996.
332. Nakabayashi K., Kudo M., Kobilka B., et al. Activation of the luteinizing hormone receptor following substitution of Ser-277 with selective hydrophobic residues in the ectodomain hinge region. J Biol Chem 2000, 275:30264-30271.
333. Zeng H., Phang T., Song Y.S., et al. The role of the hinge region of the luteinizing hormone receptor in hormone interaction and signal generation. J Biol Chem 2001, 276:3451-3458.
334. Duprez L., Parma J., Costagliola S., et al. Constitutive activation of the TSH receptor by spontaneous mutations affecting the N-terminal extracellular domain. FEBS Lett 1997, 409:469-474.
335. Kopp P., Muirhead S., Jourdain N., et al. Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (serine281⇒isoleucine) in the extracellular domain of the thyrotropin receptor. J Clin Invest 1997, 100:1634-1649.
336. Gruters A., Schoneberg T., Biebermann H., et al. Severe congenital hyperthyroidism caused by a germ-line neo mutation in the extracellular portion of the thyrotropin receptor. J Clin Endocrinol Metab 1998, 83:1431-1436.
337. Liu G., Duranteau L., Carel J.-C., et al. Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. N Engl J Med 1999, 341:1731-1736.
338. Richter-Unruh A., Wessels H.T., Menken U., et al. Male LH-independent sexual precocity in a 3.5-year-old boy caused by a somatic activating mutation of the LH receptor in a Leydig cell tumor. J Clin Endocrinol Metab 2002, 87:1052-1056.
339. Canto P., Soderlund D., Ramon G., et al. Mutational analysis of the luteinizing hormone receptor gene in two individuals with Leydig cell tumors. Am J Med Genet 2002, 108:148-152.
340. Doherty E., Pakarinen P., Tiitinen A., et al. A novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure. J Clin Endocrinol Metab 2002, 87:1151-1155.
341. Gromoll J., Simoni M., Nieschlag E. An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in hypophysectomized man. J Clin Endocrinol Metab 1996, 81:1367-1370.
342. Smits G., Latunbosun O., Delbaere A., et al. Ovarian hyperstimulation syndrome due to a mutation in the follicle stimulating hormone receptor. N Engl J Med 2003, 349:760-766.
343. Montanelli L., Delbaere A., Di Carlo C., et al. A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 2004, 89:1255-1258.
344. Montanelli L., Van Durme J.J.J., Smits G., et al. Modulation of ligand selectivity associated with activation of the transmembrane region of the human follitropin receptor. Mol Endocrinol 2004, 18:2061-2073.
345. Rodien P., Bremont C., Sanson M.L., et al. Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N Engl J Med 1998, 339:1823-1826.
346. Rodien P., Cetani F., Costagliola S., et al. Evidences for an allelic variant of the human lc/CG receptor rather than a gene duplication: functional comparison of wild-type and variant receptors. J Clin Endocrinol Metab 1998, 83:4431-4434.
347. ' non-coding regions. Mol Cell Endocrinol 1995, 111:113-123.
348. Tsai-Morris C.H., Geng Y., Buczko E., et al. A novel human luteinizing hormone receptor gene. J Clin Endocrinol Metab 1998, 83:288-291.
349. Piersma D., Berns E.M.J.J., Verhoef-Post M., et al. A common polymorphism renders the luteinizing hormone receptor protein more active by improving signal peptide function and predicts adverse outcome in breast cancer patients. J Clin Endocrinol Metab 2006, 91:1470-1476.
350. Piersma D., Verhoef-Post M., Look M.P., et al. Polymorphic variations in exon 10 of the luteinizing hormone receptor: functional consequences and associations with breast cancer. Mol Cell Endocrinol 2007, 276:63-70.
351. Laue L., Wu S.M., Kudo M., et al. Heterogeneity of activating mutations of the human luteinizing hormone receptor in male-limited precocious puberty. Biochem Mol Med 1996, 58:192-198.
352. Wunsch A., Sonntag B., Simoni M. Polymorphism of the FSH receptor and ovarian response to FSH. Ann Endocrinol (Paris) 2007, 68:160-166.
353. Yang C.Q., Chan K.Y.K., Ngan H.Y.S., et al. Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility. Carcinogenesis 2006, 27:1502-1506.
354. Simoni M., Gromoll J., Höppner W., et al. Mutational analysis of the follicle-stimulating hormone (FSH) receptor in normal men: identification and characterization of two discrete FSH receptor isoforms. J Clin Endocrinol Metab 1999, 84:751-755.
355. Sudo S., Kudo M., Wada S., et al. Genetic and functional analyses of polymorphisms in the human FSH receptor gene. Mol Hum Reprod 2002, 8:893-899.
356. Segaloff D.L., Wang H., Richards J.S. Hormonal regulation of luteinizing hormone/chorionic gonadotropin receptor mRNA in rat ovarian cells during follicular development and luteinization. Mol Endocrinol 1990, 4:1856-1865.
357. Shi H., Segaloff D.L. A role for increased lutropin/choriogonadotropin receptor (LHR) gene transcription in the follitropin-stimulated induction of the LHR in granulosa cells. Mol Endocrinol 1995, 9:734-744.
358. Chen S., Shi H., Liu X., et al. Multiple elements and protein factors coordinate the basal and cyclic adenosine 3',5'-monophosphate-induced transcription of the lutropin receptor gene in rat granulosa cells. Endocrinology 1999, 140:2100-2109.
359. Chen S., Liu X., Segaloff D.L. A novel cyclic adenosine 3',5'-monophosphate-responsive element involved in the transcriptional regulation of the lutropin receptor gene in granulosa cells. Mol Endocrinol 2000, 14:1498-1508.
360. Richards J.S., Russell D.L., Ochsner S., et al. Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization. Recent Prog Horm Res 2002, 57:195-220.
361. Richards J.S. Hormonal control of gene expression in the ovary. Endocr Rev 1994, 15:725-751.
362. Menon K.M.J., Munshi U.M., Clouser C.L., et al. Regulation of luteinizing hormone/human chorionic gonadotropin receptor expression: a perspective. Biol Reprod 2004, 70:861-866.
363. Peegel H., Randolph J.J., Midgley R., et al. In situ hybridization of luteinizing hormone/human chorionic gonadotropin receptor messenger ribonucleic acid during hormone-induced down-regulation and the subsequent recovery in rat corpus luteum. Endocrinology 1994, 135:1044-1051.
364. LaPolt P.S., Oikawa M., Xiao-Chi J., et al. Gonadotropin-induced up- and down-regulation of rat ovarian LH receptor message levels during follicular growth, ovulation and luteinization. Endocrinology 1990, 126:3277-3279.
365. Lu D.L., Peegel H., Mosier S.M., et al. Loss of lutropin/human choriogonadotropin receptor messenger ribonucleic acid during ligand-induced down-regulation occurs post transcriptionally. Endocrinology 1993, 132:235-240.
366. Peegel H., Towns R., Nair A., et al. A novel mechanism for the modulation of luteinizing hormone receptor mRNA expression in the rat ovary. Mol Cell Endocrinol 2005, 233:65-72.
367. Kash J.C., Menon K.M. Sequence-specific binding of a hormonally regulated mRNA binding protein to cytidine-rich sequences in the lutropin receptor open reading frame. Biochemistry 1999, 38:16889-16897.
368. Kash J.C., Menon K.M. Identification of a hormonally regulated luteinizing hormone/human chorionic gonadotropin receptor mRNA binding protein: increased mRNA binding during receptor down-regulation. J Biol Chem 1998, 273:10658-10664.
369. Nair A.K., Menon K.M.J. Regulation of luteinizing hormone receptor expression: evidence of translational suppression in vitro by a hormonally regulated mRNA-binding protein and its endogenous association with luteinizing hormone receptor mRNA in the ovary. J Biol Chem 2005, 280:42809-42816.
370. Nair A.K., Menon K.M.J. Isolation and characterization of a novel trans-factor for luteinizing hormone receptor mRNA from ovary. J Biol Chem 2004, 279:14937-14944.
371. Nair A.K., Kash J.C., Peegel H., et al. Post-transcriptional regulation of luteinizing hormone receptor mRNA in the ovary by a novel mRNA-binding protein. J Biol Chem 2002, 277:21468-21473.
372. Menon K.M.J., Nair A.K., Wang L., et al. Regulation of luteinizing hormone receptor mRNA expression by a specific RNA binding protein in the ovary. Mol Cell Endocrinol 2007, 260-262:109-116.
373. Zhang F.-P., Poutanen M., Wilbertz J., et al. Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice. Mol Endocrinol 2001, 15:172-183.
374. Lei Z.M., Mishra S., Zou W., et al. Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene. Mol Endocrinol 2001, 15:184-200.
375. Pietila E.M., Tuusa J.T., Apaja P.M., et al. Inefficient maturation of the rat luteinizing hormone receptor: a putative way to regulate receptor numbers at the cell surface. J Biol Chem 2005, 28:26622-26629.
376. Apaja P.M., Tuusa J.T., Pietila E.M., et al. Luteinizing hormone receptor ectodomain splice variant misroutes the full-length receptor into a subcompartment of the endoplasmic reticulum. Mol Biol Cell 2006, 17:2243-2255.
377. Nakamura K., Yamashita S., Omori Y., et al. A splice variant of the human luteinizing hormone (LH) receptor modulates the expression of wild-type human LH receptor. Mol Endocrinol 2004, 18:1461-1470.
378. Yamashita S., Nakamura K., Omori Y., et al. Association of human follitropin (FSH) receptor with splicing variant of human lutropin/choriogonadotropin receptor negatively controls the expression of human FSH receptor. Mol Endocrinol 2005, 19:2099-2111.
379. Pierce K.L., Premont R.T., Lefkowitz R.J. Seven-transmembrane receptors. Nat Rev Mol Cell Biol 2002, 3:639-650.
380. Lefkowitz R.J., Pierce K.L., Luttrell L.M. Dancing with different partners: protein kinase A phosphorylation of seven membrane-spanning receptors regulates their G protein-coupling specificity. Mol Pharmacol 2002, 62:971-974.
381. Pitcher J.A., Freedman N.J., Lefkowitz R.J. G protein-coupled receptor kinases. Ann Rev Biochem 1998, 67:653-692.
382. Premont R.T., Inglese J., Lefkowitz R.J. Protein kinases that phosphorylate activated G protein-coupled receptors. FASEB J 1995, 9:175-182.
383. Hipkin R.W., Sánchez-Yagüe J., Ascoli M. Agonist-induced phosphorylation of the luteinizing hormone/chorionic gonadotropin (LH/CG) receptor expressed in a stably transfected cell line. Mol Endocrinol 1993, 7:823-832.
384. Min L., Ascoli M. Effect of activating and inactivating mutations on the phosphorylation and trafficking of the human lutropin/choriogonadotropin receptor. Mol Endocrinol 2000, 14:1797-1810.
385. Wang Z., Liu X., Ascoli M. Phosphorylation of the lutropin/choriogonadotropin receptor facilitates uncoupling of the receptor from adenylyl cyclase and endocytosis of the bound hormone. Mol Endocrinol 1997, 11:183-192.
386. Wang Z., Hipkin R.W., Ascoli M. Progressive cytoplasmic tail truncations of the lutropin-choriogonadotropin receptor prevent agonist- or phorbol ester-induced phosphorylation, impair agonist- or phorbol ester-induced desensitization and enhance agonist-induced receptor down-regulation. Mol Endocrinol 1996, 10:748-759.
387. Lazari M.F.M., Liu X., Nakamura K., et al. Role of G protein-coupled receptor kinases on the agonist-induced phosphorylation, and internalization of the follitropin receptor. Mol Endocrinol 1999, 13:866-878.
388. Nakamura K., Hipkin R.W., Ascoli M. The agonist-induced phosphorylation of the rat follitropin receptor (rFSHR) maps to the first and third intracellular loops. Mol Endocrinol 1998, 12:580-591.
389. Hipkin R.W., Liu X., Ascoli M. Truncation of the c-terminal tail of the follitropin (FSH) receptor does not impair the agonist- or phorbol ester-induced receptor phosphorylation and uncoupling. J Biol Chem 1995, 270:26683-26689.
390. Quintana J., Hipkin R.W., Sánchez-Yagüe J., et al. Follitropin (FSH) and a phorbol ester stimulate the phosphorylation of the FSH receptor in intact cells. J Biol Chem 1994, 269:8772-8779.
391. Kara E., Crepieux P., Gauthier C., et al. A phosphorylation cluster of five serine and threonine residues in the c-terminus of the follicle-stimulating hormone receptor is important for desensitization but not for β-arrestin-mediated erk activation. Mol Endocrinol 2006, 20:3014-3026.
392. Hipkin R.W., Wang Z., Ascoli M. Human chorionic gonadotropin- and phorbol ester stimulated phosphorylation of the LH/CG receptor maps to serines 635, 639, 645 and 652 in the c-terminal cytoplasmic tail. Mol Endocrinol 1995, 9:151-158.
393. Lazari M.F.M., Bertrand J.E., Nakamura K., et al. Mutation of individual serine residues in the c-terminal tail of the lutropin/choriogonadotropin (LH/CG) receptor reveal distinct structural requirements for agonist-induced uncoupling and agonist-induced internalization. J Biol Chem 1998, 273:18316-18324.
394. Hall R.A., Premont R.T., Lefkowitz R.J. Heptahelical receptor signaling: beyond the G protein paradigm. J Cell Biol 1999, 145:927-932.
395. Perry S.J., Lefkowitz R.J. Arresting developments in heptahelical receptor signaling and regulation. Trends Cell Biol 2002, 12:130-138.
396. Min L., Galet C., Ascoli M. The association of arrestin-3 with the human lutropin/choriogonadotropin receptor depends mostly on receptor activation rather than on receptor phosphorylation. J Biol Chem 2002, 277:702-710.
397. Bhaskaran R.S., Min L., Krishnamurthy H., et al. Studies with chimeras of the gonadotropin receptors reveal the importance of third intracellular loop threonines on the formation of the receptor/non-visual arrestin complex. Biochemistry 2003, 42:13950-13959.
398. Li S., Liu X., Min L., et al. Mutations of the second extracellular loop of the human lutropin receptor emphasize the importance of receptor activation and de-emphasize the importance of receptor phosphorylation in agonist-induced internalization. J Biol Chem 2001, 276:7968-7973.
399. Kishi H., Ascoli M. Multiple distant amino acid residues present in the serpentine region of the follitropin receptor modulate the rate of agonist-induced internalization. J Biol Chem 2000, 275:31030-31037.
400. Kishi H., Krishnamurthy H., Galet C., et al. Identification of a short linear sequence present in the c-terminal tail of the rat follitropin receptor that modulates arrestin-3 binding in a phosphorylation-independent fashion. J Biol Chem 2002, 277:21939-21946.
401. Krishnamurthy H., Galet C., Ascoli M. The association of arrestin-3 with the follitropin receptor depends on receptor activation and phosphorylation. Mol Cell Endocrinol 2003, 204:127-140.
402. Ascoli M. Lysosomal accumulation of the hormone-receptor complex during receptor-mediated endocytosis of human choriogonadotropin. J Cell Biol 1984, 99:1242-1250.
403. Nakamura K., Ascoli M. A dileucine-based motif in the c-terminal tail of the lutropin/choriogonadotropin receptor inhibits endocytosis of the agonist-receptor complex. Mol Pharmacol 1999, 56:728-736.
404. Kishi M., Ascoli M. The c-terminal tail of the rat lutropin/choriogonadotropin receptor independently modulates hCG-induced internalization of the cell surface receptor and the lysosomal targeting of the internalized hCG-receptor complex. Mol Endocrinol 2000, 14:926-936.
405. Ghinea N., Vuhai M.T., Groyer-Picard M.-T., et al. Pathways of internalization of the hCG/LH receptor: immunoelectron microscopic studies in Leydig cells and transfected l cells. J Cell Biol 1992, 118:1347-1358.
406. Baratti-Elbaz C., Chinea N., Lahuna O., et al. Internalization and recycling pathways of the thyrotropin receptor. Mol Endocrinol 1999, 13:1751-1765.
407. Lloyd C.E., Ascoli M. On the mechanisms involved in the regulation of the cell surface receptors for human choriogonadotropin and mouse epidermal growth factor in cultured Leydig tumor cells. J Cell Biol 1983, 96:521-526.
408. Wang H., Segaloff D.L., Ascoli M. Lutropin/choriogonadotropin down-regulates its receptor by both receptor mediated endocytosis and a cAMP-dependent reduction in receptor mRNA. J Biol Chem 1991, 266:780-785.
409. Nakamura K., Lazari M.F.M., Li S., et al. Role of the rate of internalization of the agonist-receptor complex on the agonist-induced down-regulation of the lutropin/choriogonadotropin receptor. Mol Endocrinol 1999, 13:1295-1304.
410. Bhaskaran R.S., Ascoli M. The post-endocytotic fate of the gonadotropin receptors is an important determinant of the desensitization of gonadotropin responses. J Mol Endocrinol 2005, 34:447-457.
411. Kishi M., Liu X., Hirakawa T., et al. Identification of two distinct structural motifs that, when added to the c-terminal tail of the rat lutropin receptor, redirect the internalized hormone-receptor complex from a degradation to a recycling pathway. Mol Endocrinol 2001, 15:1624-1635.
412. Galet C., Min L., Narayanan R., et al. Identification of a transferable two amino acid motif (gt) present in the c-terminal tail of the human lutropin receptor that redirects internalized G protein-coupled receptors from a degradation to a recycling pathway. Mol Endocrinol 2003, 17:411-422.
413. Galet C., Hirakawa T., Ascoli M. The postendocytotic trafficking of the hLHR is mediated by a transferable motif consisting of the c-terminal cysteine and an upstream leucine. Mol Endocrinol 2004, 18:434-446.
414. Krishnamurthy H., Kishi H., Shi M., et al. Post-endocytotic trafficking of the FSH/FSH receptor complex. Mol Endocrinol 2003, 17:2162-2176.
415. Hirakawa T., Galet C., Kishi M., et al. GIPC binds to the human lutropin receptor (LHR) through an unusual PDZ domain binding motif and it regulates the sorting of the internalized human choriogonadotropin (hCG) and the density of cell surface LHR. J Biol Chem 2003, 278:49348-49357.
416. Dierich A., Sairam M.R., Monaco L., et al. Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc Natl Acad Sci U S A 1998, 95:13612-13617.
417. Abel M.H., Wootton A.N., Wilkins V., et al. The effect of a null mutation in the follicle-stimulating hormone receptor gene on mouse reproduction. Endocrinology 2000, 141:1795-1803.
418. Rao C.V., Lei Z.M. The past, present and future of nongonadal LH/hCG actions in reproductive biology and medicine. Mol Cell Endocrinol 2007, 269:2-8.
419. Toth P., Lukacs H., Gimes G., et al. Clinical importance of vascular LH/hCG receptors: a review. Reprod Biol 2001, 1:5-11.
420. Rao C.V. An overview of the past, present, and future of nongonadal LH/hCG actions in reproductive biology and medicine. Semin Reprod Med 2001, 19:7-17.
421. Filicori M., Fazleabas A.T., Huhtaniemi I., et al. Novel concepts of human chorionic gonadotropin: reproductive system interactions and potential in the management of infertility. Fertil Steril 2005, 84:275-284.
422. Ahtiainen P., Rulli S., Pakarainen T., et al. Phenotypic characterisation of mice with exaggerated and missing LH/hCG action. Mol Cell Endocrinol 2007, 260-262:255-263.
423. Berndt S., d'Hauterive S.P., Blacher S., et al. Angiogenic activity of human chorionic gonadotropin through LH receptor activation on endothelial and epithelial cells of the endometrium. FASEB J 2006, 20:2630-2632.
424. Lacroix A., Hamet P., Boutin J.M. Leuprolide acetate therapy in luteinizing hormone-dependent Cushing's syndrome. N Engl J Med 1999, 341:1577-1581.
425. Lacroix A., N'Diaye N., Tremblay J., et al. Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocr Rev 2001, 22:75-110.
426. Kumar T.R., Wang Y., Matzuk M.M. Gonadotropins are essential modifier factors for gonadal tumor development in inhibin-deficient mice. Endocrinology 1996, 137:4210-4216.
427. Kananen K., Rillianawati Paukku T., Markkular M., et al. Suppression of gonadotropins inhibits gonadal tumorogenesis in mice transgenic for the mouse inhibin-a subunit promoter/sv40 t-antigen fusion gene. Endocrinology 1997, 138:3521-3531.
428. Rilianawati Paukku T., Kero J., et al. Direct luteinizing hormone action triggers adrenocortical tumorigenesis in castrated mice transgenic for the murine inhibin α-subunit promoter/simian virus 40 t-antigen fusion gene. Mol Cell Endocrinol 1998, 12:801-809.
429. Kero J., Poutanen M., Zhang F.P., et al. Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex. J Clin Invest 2000, 105:633-641.
430. Sun L., Peng Y., Sharrow A.C., et al. FSH directly regulates bone mass. Cell 2006, 125:247-260.
431. Williams G.R. Hypogonadal bone loss: sex steroids or gonadotropins?. Endocrinology 2007, 148:2610-2612.
432. Gao J., Tiwari-Pandey R., Samadfam R., et al. Altered ovarian function affects skeletal homeostasis independent of the action of follicle-stimulating hormone. Endocrinology 2007, 148:2613-2621.
433. Porter A.T. FACRO, Ben-Josef E. Humoral mechanisms in prostate cancer: a role for FSH. Urol Oncol 2001, 6:131-138.
434. Kumar T.R. What have we learned about gonadotropin function from gonadotropin subunit and receptor knockout mice?. Reproduction 2005, 130:293-302.
435. Pakarainen T., Zhang F.-P., Poutanen M., et al. Fertility in luteinizing hormone receptor-knockout mice after wild-type ovary transplantation demonstrates redundancy of extragonadal luteinizing hormone action. J Clin Invest 2005, 115:1862-1868.
436. Chudgar D., Lei Z., Rao C.V. Orthotopic transplantation of LH receptor knockout and wild-type ovaries. Life Sci 2005, 77:2656-2662.
437. Quintana J., Wang H., Ascoli M. The regulation of the binding affinity of the luteinizing hormone/choriogonadotropin receptor by sodium ions is mediated by a highly conserved aspartate located in the second transmembrane domain of G protein-coupled receptors. Mol Endocrinol 1993, 7:767-775.
438. Osuga Y., Hayashi M., Kudo M., et al. Co-expression of defective luteinizing hormone receptor fragments partially reconstitutes ligand-induced signal generation. J Biol Chem 1997, 272:25006-25012.
439. Ji I., Lee C., Song Y., et al. Cis- and trans-activation of hormone receptors: the LH receptor. Mol Endocrinol 2002, 16:1299-1308.
440. Urizar E., Montanelli L., Loy T., et al. Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity. EMBO J 2005, 24:1954-1964.
441. +2 mobilization. J Biol Chem 1992, 267:4479-4488.
442. +2 mobilization by the LH receptor expressed in Xenopus oocytes independent of 3',5'-cyclic adenosine monophosphate formation: evidence for parallel activation of two signaling pathways. Mol Endocrinol 1992, 6:272-278.
443. Ascoli M., Pignataro O.P., Segaloff D.L. The inositol phosphate/diacylglycerol pathway in ma-10 Leydig tumor cells: activation by arginine vasopressin and lack of effect of epidermal growth factor and human choriogonadotropin. J Biol Chem 1989, 264:6674-6681.
444. Rebois R.V., Patel J. Phorbol ester causes desensitization of gonadotropin-responsive adenylate cyclase in a murine Leydig tumor cell line. J Biol Chem 1985, 260:8026-8031.
445. Zhu X., Gilbert S., Birnbaumer M., et al. Dual signaling potential is common among Gs-coupled receptors and dependent on receptor density. Mol Pharmacol 1994, 46:460-469.
446. Hirakawa T., Galet C., Ascoli M. MA-10 cells transfected with the human lutropin/choriogonadotropin receptor (hLHR): a novel experimental paradigm to study the functional properties of the hLHR. Endocrinology 2002, 143:1026-1035.
447. Donadeu F.X., Ascoli M. The differential effects of the gonadotropin receptors on aromatase expression in primary cultures of immature rat granulosa cells are highly dependent on the density of receptors expressed and the activation of the inositol phosphate cascade. Endocrinology 2005, 146:3907-3916.
448. Andric N., Ascoli M. A delayed, gonadotropin-dependent and growth-factor mediated activation of the erk1/2 cascade negatively regulates aromatase expression in granulosa cells. Mol Endocrinol 2006, 20:3308-3320.
449. Herrlich A., Kuhn B., Grosse R., et al. Involvement of Gs and Gi proteins in dual coupling of the luteinizing hormone receptor to adenylyl cyclase and phospholipase C. J Biol Chem 1996, 271:16764-16772.
450. sα and pertussis toxin-catalyzed adp-ribosylation of giα. Mol Endocrinol 1997, 11:538-549.
451. Rajagopalan-Gupta R., Lamm M.L.G., Mukherjee S., et al. Luteinizing hormone/choriogonadotropin receptor-mediated activation of heterotrimeric guanine nucleotide binding proteins in ovarian follicular membranes. Endocrinology 1998, 139:4547-4555.
452. Hirakawa T., Ascoli M. A constitutively active somatic mutation of the human lutropin receptor found in Leydig cell tumors activates the same families of G proteins as germ line mutations associated with Leydig cell hyperplasia. Endocrinology 2003, 144:3872-3878.
453. Kühn B., Gudermann T. The luteinizing hormone receptor activates phospholipase C via preferential coupling to Gi2. Biochemistry 1999, 38:12490-12498.
454. Laue L., Chan W.-Y., Hsueh A.J.W., et al. Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precoious puberty. Proc Natl Acad Sci U S A 1995, 92:1906-1910.
455. Muller J., Gondos B., Kosugi S., et al. Severe testotoxicosis phenotype associated with Asp578>Tyr mutation of the lutrophin/choriogonadotrophin receptor gene. J Med Genet 1998, 35:340-341.
456. Yano K., Kohn L., Saji M., et al. A case of male-limited precocious puberty caused by a point mutaion in the second transmembrane domain of the luteinizing hormone choriogonadotropin receptor gene. Biochem Biophys Res Commun 1996, 220:1036-1042.
457. Latronico A.C., Abell A.N., Arnhold I.J.P., et al. A unique constitutively activating mutation in third transmembrane helix of luteinizing hormone receptor causes sporadic male gonadotropin-independent precocious puberty. J Clin Endocrinol Metab 1998, 83:2435-2440.
458. Hunzicker-Dunn M., Maizels E.T. FSH signaling pathways in immature granulosa cells that regulate target gene expression: branching out from protein kinase A. Cell Signal 2006, 18:1351-1359.
459. Alam H., Maizels E.T., Park Y., et al. Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/akt/ras homolog enriched in brain (Rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation. J Biol Chem 2004, 279:19431-19440.
460. Cottom J., Salvador L.M., Maizels E.T., et al. Follicle-stimulating hormone activates extracellular signal-regulated kinase but not extracellular signal-regulated kinase kinase through a 100-kda phosphotyrosine phosphatase. J Biol Chem 2003, 278:7167-7179.
461. Salvador L.M., Maizels E., Hales D.B., et al. Acute signaling by the LH receptor is independent of protein kinase C activation. Endocrinology 2002, 143:2986-2994.
462. Tajima K., Yoshii K., Fukuda S., et al. Luteinizing hormone-induced extracellular-signal regulated kinase activation differently modulates progesterone and androstenedione production in bovine theca cells. Endocrinology 2005, 146:2903-2910.
463. Hirakawa T., Ascoli M. The lutropin/choriogonadotropin receptor-induced phosphorylation of the extracellular signal regulated kinases in Leydig cells is mediated by a protein kinase A-dependent activation of ras. Mol Endocrinol 2003, 17:2189-2200.
464. Shiraishi K, Ascoli M. A co-culture system reveals the involvement of intercellular pathways as mediators of the lutropin receptor (LHR)-stimulated ERK1/2 phosphorylation in leydig cells. Exp Cell Res doi:10.1016/j.yexcr.2007.06.025 2007.
465. Shiraishi K., Ascoli M. Lutropin/choriogonadotropin (LH/CG) stimulates the proliferation of primary cultures of rat Leydig cells through a pathway that involves activation of the ERK1/2 cascade. Endocrinology 2007, 148:3214-3225.
466. Shiraishi K., Ascoli M. Activation of the lutropin/choriogonadotropin receptor (LHR) in MA-10 cells stimulates tyrosine kinase cascades that activate ras and the extracellular signal regulated kinases (ERK1/2). Endocrinology 2006, 147:3419-3427.
467. Martinelle N., Holst M., Soder O., et al. Extracellular signal-regulated kinases are involved in the acute activation of steroidogenesis in immature rat Leydig cells by human chorionic gonadotropin. Endocrinology 2004, 145:4629-4634.
468. Walker W.H., Cheng J. FSH and testosterone signaling in Sertoli cells. Reproduction 2005, 130:15-28.
469. Mizutani T., Shiraishi K., Welsh T., et al. Activation of the lutropin/choriogonadotropin receptor in MA-10 cells leads to the tyrosine phosphorylation of the focal adhesion kinase by a pathway that involves Src family kinases. Mol Endocrinol 2006, 20:619-630.
470. Carvalho C.R.O., Carvalheira J.B.C., Lima M.H.M., et al. Novel signal transduction pathway for luteinizing hormone and its interaction with insulin: activation of Janus kinase/signal transducer and activator of transcription and phosphoinositol 3-kinase/Akt pathways. Endocrinology 2003, 144:638-647.
471. Park J.-Y., Su Y.-Q., Ariga M., et al. EGF-like growth factors as mediators of LH action in the ovulatory follicle. Science 2004, 303:682-684.
472. Ashkenazi H., Cao X., Motola S., et al. Epidermal growth factor family members: endogenous mediators of the ovulatory response. Endocrinology 2005, 146:77-84.
473. Conti M., Hsieh M., Park J.Y., et al. Role of the epidermal growth factor network in ovarian follicles. Mol Endocrinol 2005, 20:715-723.
474. Hsieh M., Conti M. G-protein-coupled receptor signaling and the EGF network in endocrine systems. Trends Endocrinol Metab 2005, 16:320-326.
475. Hsieh M., Lee D., Panigone S., et al. Luteinizing hormone-dependent activation of the epidermal growth factor network is essential for ovulation. Mol Cell Biol 2007, 27:1914-1924.
476. Wayne C.M., Fan H.-Y., Cheng X., et al. Follicle-stimulating hormone induces multiple signaling cascades: evidence that activation of Rous sarcoma oncogene, RAS, and the epidermal growth factor receptor are critical for granulosa cell differentiation. Mol Endocrinol 2007, 21:1940-1957.
477. Richards J.S. Perspective: the ovarian follicle. A perspective in 2001. Endocrinology 2001, 142:2184-2193.
478. Ascoli M. Potential Leydig cell mitogenic signals generated by the wild-type and constitutively active mutants of the lutropin/choriogonadotropin receptor. Mol Cell Endocrinol 2007, 260-262:244-248.
479. Ahtiainen P., Rulli S., Pakarainen T., et al. Phenotypic characterization of mice with exaggerated and missing LH/hCG action. Mol Cell Endocrinol 2007, 260-262:255-263.
480. Ascoli M. Potential Leydig cell mitogenic signals generated by the wild-type and constitutively active mutants of the lutropin/choriogonadotropin receptor. Mol Cell Endocrinol 2007, 260-262:244-248.
481. Ascoli M., Fanelli F., Segaloff D.L. The lutropin/choriogonadotropin receptor: a 2002 perspective. Endocr Rev 2002, 23:141-174.
482. Boime I., Garcia-Campayo V., Hsueh A.J.W. The glycoprotein hormones and their receptors. Reproductive Endocrinology: Physiology, Pathophysiology, and Clinica Management 2004, 75-92. Saunders, Philadelphia. J. Strauss, R.L. Barbieri (Eds.).
483. Conti M., Hsieh M., Park J.Y., et al. Role of the EGF network in ovarian follicles. Mol Endocrinol 2005, 20:715-723.
484. Costagliola S., Urizar E., Mendive F., et al. Specificity and promiscuity of gonadotropin receptors. Reproduction 2005, 130:275-281.
485. Fan Q.R., Hendrickson W.A. Structure of human follicle-stimulating hormone in complex with its receptor. Nature 2005, 433:269-277.
486. Hearn M.T.W., Gomme P.T. Molecular architecture and biorecognition processes of the cystine knot protein superfamily: Part I. The glycoprotein hormones. J Mol Recog 2000, 13:223-278.
487. Hunzicker-Dunn M., Maizels E.T. FSH signaling pathways in immature granulosa cells that regulate target gene expression: branching out from protein kinase A. Cell Signal 2006, 18:1351-1359.
488. Lapthorn A.J., Harris D.C., Littlejohn A., et al. Crystal-structure of human chorionic-gonadotropin. Nature 1994, 369:455-461.
489. Latronico A.C., Segaloff D.L. Insights learned from L457(3.43)R, an activating mutant of the human lutropin receptor. Mol Cell Endocrinol 2007, 260-262:287-293.
490. Puett D., Wu C.B., Narayan P. The tie that binds: design of biologically active single-chain human chorionic gonadotropins and a gonadotropin-receptor complex using protein engineering. Biol Reprod 1998, 58:1337-1342.
491. Tegoni M., Spinelli S., Verhoeyen M., et al. Crystal structure of a ternary complex between human chorionic gonadotropin (hCG) and two Fv fragments specific for the alpha and beta-subunits. J Mol Biol 1999, 289:1375-1385.
492. Themmen A.P.N. An update of the pathophysiology of human gonadotrophin subunit and receptor gene mutations and polymorphisms. Reproduction 2005, 130:263-274.
493. Wu H., Lustbader J.W., Liu Y., et al. Structure of human chorionic-gonadotropin at 2.6-Angstrom resolution from MAD analysis of theselenomethionyl protein. Structure 1994, 2:545-558.